| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mental Disorders | 384 | 2024 | 6845 | 22.050 |
Why?
|
| Military Personnel | 137 | 2024 | 1246 | 20.980 |
Why?
|
| Health Surveys | 288 | 2024 | 4061 | 14.110 |
Why?
|
| Suicide, Attempted | 115 | 2024 | 1402 | 14.040 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 152 | 2024 | 1988 | 11.690 |
Why?
|
| Stress Disorders, Post-Traumatic | 126 | 2024 | 4575 | 8.920 |
Why?
|
| Depressive Disorder, Major | 105 | 2024 | 4761 | 8.340 |
Why?
|
| Suicidal Ideation | 89 | 2024 | 1447 | 8.310 |
Why?
|
| Anxiety Disorders | 146 | 2024 | 2720 | 7.830 |
Why?
|
| Suicide | 66 | 2024 | 1601 | 7.210 |
Why?
|
| Mental Health Services | 75 | 2024 | 1730 | 6.590 |
Why?
|
| Life Change Events | 70 | 2021 | 952 | 6.340 |
Why?
|
| Prevalence | 329 | 2024 | 15732 | 6.070 |
Why?
|
| Comorbidity | 263 | 2024 | 10508 | 6.030 |
Why?
|
| Students | 68 | 2024 | 1741 | 5.940 |
Why?
|
| World Health Organization | 81 | 2023 | 1322 | 5.790 |
Why?
|
| Mood Disorders | 63 | 2024 | 1127 | 5.670 |
Why?
|
| Resilience, Psychological | 38 | 2024 | 788 | 5.380 |
Why?
|
| Interview, Psychological | 48 | 2024 | 809 | 4.480 |
Why?
|
| Mental Health | 83 | 2024 | 3250 | 4.400 |
Why?
|
| Substance-Related Disorders | 90 | 2024 | 4420 | 4.200 |
Why?
|
| Age of Onset | 97 | 2023 | 3306 | 4.200 |
Why?
|
| Psychiatric Status Rating Scales | 108 | 2024 | 6019 | 4.030 |
Why?
|
| Adolescent | 491 | 2024 | 88323 | 4.010 |
Why?
|
| Depressive Disorder | 96 | 2024 | 3728 | 3.780 |
Why?
|
| Cross-Cultural Comparison | 32 | 2019 | 635 | 3.780 |
Why?
|
| Adult | 741 | 2024 | 221200 | 3.740 |
Why?
|
| Absenteeism | 29 | 2013 | 247 | 3.600 |
Why?
|
| Afghan Campaign 2001- | 28 | 2024 | 298 | 3.500 |
Why?
|
| Phobic Disorders | 35 | 2023 | 439 | 3.490 |
Why?
|
| Alcoholism | 51 | 2024 | 1973 | 3.410 |
Why?
|
| Cost of Illness | 37 | 2023 | 1936 | 3.400 |
Why?
|
| Young Adult | 285 | 2024 | 59254 | 3.270 |
Why?
|
| Disasters | 17 | 2017 | 519 | 3.250 |
Why?
|
| Depression | 75 | 2024 | 8124 | 3.120 |
Why?
|
| Universities | 51 | 2024 | 993 | 3.110 |
Why?
|
| Male | 771 | 2024 | 360841 | 3.060 |
Why?
|
| United States | 346 | 2024 | 72335 | 3.050 |
Why?
|
| Violence | 22 | 2020 | 937 | 3.010 |
Why?
|
| Humans | 1128 | 2024 | 761578 | 2.990 |
Why?
|
| Female | 799 | 2024 | 392688 | 2.970 |
Why?
|
| Veterans | 12 | 2024 | 2649 | 2.870 |
Why?
|
| Risk Assessment | 74 | 2024 | 23996 | 2.720 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 16 | 2024 | 1081 | 2.620 |
Why?
|
| Sex Offenses | 9 | 2022 | 352 | 2.590 |
Why?
|
| Developed Countries | 23 | 2021 | 449 | 2.530 |
Why?
|
| Middle Aged | 480 | 2024 | 220917 | 2.410 |
Why?
|
| Chronic Disease | 48 | 2023 | 9319 | 2.340 |
Why?
|
| Risk Factors | 278 | 2024 | 74212 | 2.310 |
Why?
|
| Crime Victims | 10 | 2019 | 347 | 2.270 |
Why?
|
| Psychotherapy | 20 | 2024 | 1647 | 2.100 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 26 | 2021 | 3708 | 1.960 |
Why?
|
| Patient Acceptance of Health Care | 43 | 2024 | 3205 | 1.890 |
Why?
|
| Self Report | 26 | 2023 | 3725 | 1.890 |
Why?
|
| Cross-Sectional Studies | 157 | 2024 | 26127 | 1.890 |
Why?
|
| Employment | 19 | 2017 | 1118 | 1.850 |
Why?
|
| Child of Impaired Parents | 14 | 2017 | 460 | 1.840 |
Why?
|
| Psychometrics | 36 | 2022 | 3065 | 1.760 |
Why?
|
| Socioeconomic Factors | 70 | 2020 | 7827 | 1.710 |
Why?
|
| Stress, Psychological | 44 | 2024 | 4481 | 1.690 |
Why?
|
| Urban Population | 17 | 2018 | 2036 | 1.690 |
Why?
|
| Severity of Illness Index | 91 | 2024 | 15843 | 1.610 |
Why?
|
| Mass Screening | 29 | 2022 | 5428 | 1.600 |
Why?
|
| Social Class | 24 | 2019 | 2004 | 1.590 |
Why?
|
| Affective Symptoms | 8 | 2017 | 417 | 1.560 |
Why?
|
| Panic Disorder | 24 | 2021 | 613 | 1.510 |
Why?
|
| Disability Evaluation | 14 | 2021 | 1836 | 1.510 |
Why?
|
| Psychotic Disorders | 20 | 2024 | 3223 | 1.440 |
Why?
|
| Self-Injurious Behavior | 14 | 2024 | 566 | 1.440 |
Why?
|
| Anxiety | 37 | 2024 | 4573 | 1.390 |
Why?
|
| Residence Characteristics | 19 | 2024 | 2095 | 1.390 |
Why?
|
| Longitudinal Studies | 62 | 2024 | 14607 | 1.380 |
Why?
|
| Developing Countries | 24 | 2022 | 2885 | 1.380 |
Why?
|
| Child Abuse | 16 | 2023 | 1077 | 1.370 |
Why?
|
| Aged | 234 | 2024 | 169308 | 1.360 |
Why?
|
| Marriage | 17 | 2019 | 351 | 1.330 |
Why?
|
| International Classification of Diseases | 13 | 2019 | 909 | 1.330 |
Why?
|
| Public Housing | 3 | 2016 | 140 | 1.320 |
Why?
|
| Antidepressive Agents | 16 | 2024 | 2897 | 1.310 |
Why?
|
| Saudi Arabia | 8 | 2024 | 210 | 1.290 |
Why?
|
| Income | 25 | 2019 | 1877 | 1.280 |
Why?
|
| Age Factors | 86 | 2024 | 18398 | 1.280 |
Why?
|
| Accidents, Traffic | 10 | 2022 | 816 | 1.270 |
Why?
|
| Health Status | 28 | 2020 | 4077 | 1.260 |
Why?
|
| Health Care Surveys | 17 | 2018 | 2426 | 1.260 |
Why?
|
| Accidents, Occupational | 6 | 2014 | 249 | 1.250 |
Why?
|
| Disabled Persons | 11 | 2021 | 1225 | 1.240 |
Why?
|
| Adult Survivors of Child Abuse | 9 | 2023 | 294 | 1.210 |
Why?
|
| Efficiency | 10 | 2009 | 476 | 1.210 |
Why?
|
| Forecasting | 16 | 2020 | 2928 | 1.180 |
Why?
|
| Internationality | 18 | 2019 | 1001 | 1.170 |
Why?
|
| Sex Factors | 82 | 2021 | 10554 | 1.160 |
Why?
|
| Educational Status | 32 | 2020 | 2522 | 1.150 |
Why?
|
| Epidemiologic Research Design | 9 | 2013 | 368 | 1.150 |
Why?
|
| Combat Disorders | 4 | 2024 | 301 | 1.140 |
Why?
|
| Marital Status | 11 | 2019 | 426 | 1.130 |
Why?
|
| Agoraphobia | 12 | 2019 | 177 | 1.100 |
Why?
|
| Alcohol-Related Disorders | 7 | 2020 | 238 | 1.100 |
Why?
|
| Impulsive Behavior | 7 | 2023 | 346 | 1.100 |
Why?
|
| Logistic Models | 58 | 2024 | 13255 | 1.080 |
Why?
|
| Stress Disorders, Traumatic | 2 | 2019 | 50 | 1.080 |
Why?
|
| Interviews as Topic | 33 | 2021 | 2696 | 1.060 |
Why?
|
| Patient Dropouts | 6 | 2020 | 412 | 1.050 |
Why?
|
| Tobacco Use Disorder | 13 | 2021 | 703 | 1.050 |
Why?
|
| Cyclonic Storms | 5 | 2011 | 116 | 1.050 |
Why?
|
| Activities of Daily Living | 17 | 2018 | 2421 | 1.050 |
Why?
|
| Adaptation, Psychological | 34 | 2020 | 2629 | 1.040 |
Why?
|
| Diseases in Twins | 32 | 2002 | 446 | 1.030 |
Why?
|
| Models, Psychological | 13 | 2019 | 829 | 1.010 |
Why?
|
| ROC Curve | 22 | 2023 | 3578 | 0.990 |
Why?
|
| Family | 27 | 2013 | 3194 | 0.980 |
Why?
|
| Psychopathology | 12 | 2023 | 432 | 0.970 |
Why?
|
| Child Behavior Disorders | 9 | 2013 | 804 | 0.970 |
Why?
|
| Demography | 25 | 2021 | 1648 | 0.970 |
Why?
|
| Bipolar Disorder | 25 | 2024 | 5092 | 0.960 |
Why?
|
| Motor Vehicles | 8 | 2023 | 282 | 0.960 |
Why?
|
| Population Surveillance | 19 | 2018 | 2598 | 0.950 |
Why?
|
| Marijuana Abuse | 8 | 2018 | 411 | 0.940 |
Why?
|
| Poverty | 8 | 2018 | 2697 | 0.940 |
Why?
|
| Social Environment | 27 | 2010 | 1020 | 0.930 |
Why?
|
| Adolescent Behavior | 6 | 2020 | 1190 | 0.930 |
Why?
|
| Data Collection | 30 | 2012 | 3322 | 0.910 |
Why?
|
| Models, Statistical | 21 | 2024 | 5079 | 0.900 |
Why?
|
| Conduct Disorder | 5 | 2009 | 245 | 0.900 |
Why?
|
| Sampling Studies | 23 | 2009 | 615 | 0.890 |
Why?
|
| Complementary Therapies | 12 | 2017 | 486 | 0.870 |
Why?
|
| Age Distribution | 25 | 2019 | 2879 | 0.870 |
Why?
|
| United States Department of Veterans Affairs | 4 | 2024 | 928 | 0.860 |
Why?
|
| Health Services Needs and Demand | 14 | 2019 | 1403 | 0.840 |
Why?
|
| Fear | 11 | 2023 | 1477 | 0.840 |
Why?
|
| China | 16 | 2017 | 2374 | 0.830 |
Why?
|
| Lung Diseases, Obstructive | 10 | 2001 | 308 | 0.830 |
Why?
|
| Firearms | 3 | 2021 | 625 | 0.830 |
Why?
|
| Attitude to Health | 11 | 2013 | 2025 | 0.820 |
Why?
|
| Occupational Diseases | 7 | 2021 | 1490 | 0.810 |
Why?
|
| Smoking | 26 | 2020 | 9053 | 0.800 |
Why?
|
| Health Services Accessibility | 20 | 2022 | 5440 | 0.800 |
Why?
|
| Domestic Violence | 5 | 2017 | 182 | 0.790 |
Why?
|
| Needs Assessment | 9 | 2015 | 1139 | 0.790 |
Why?
|
| Internal-External Control | 13 | 2015 | 358 | 0.790 |
Why?
|
| Anger | 6 | 2021 | 406 | 0.790 |
Why?
|
| Odds Ratio | 45 | 2018 | 9646 | 0.780 |
Why?
|
| Retrospective Studies | 98 | 2024 | 80646 | 0.780 |
Why?
|
| Anxiety, Separation | 3 | 2015 | 86 | 0.770 |
Why?
|
| Risk | 32 | 2023 | 9610 | 0.770 |
Why?
|
| Ownership | 2 | 2021 | 339 | 0.770 |
Why?
|
| Workplace | 9 | 2009 | 863 | 0.760 |
Why?
|
| Wounds and Injuries | 11 | 2021 | 2491 | 0.760 |
Why?
|
| Reproducibility of Results | 56 | 2022 | 20099 | 0.750 |
Why?
|
| Spain | 17 | 2024 | 487 | 0.740 |
Why?
|
| Time Factors | 61 | 2020 | 39970 | 0.730 |
Why?
|
| Alcohol Drinking | 17 | 2023 | 4028 | 0.730 |
Why?
|
| Follow-Up Studies | 52 | 2024 | 39107 | 0.730 |
Why?
|
| Employee Performance Appraisal | 5 | 2011 | 86 | 0.730 |
Why?
|
| Prospective Studies | 66 | 2024 | 54423 | 0.720 |
Why?
|
| Health Care Costs | 14 | 2023 | 3242 | 0.720 |
Why?
|
| Lung Abscess | 1 | 2020 | 40 | 0.710 |
Why?
|
| Epidemiologic Methods | 18 | 2012 | 1336 | 0.710 |
Why?
|
| Internet | 9 | 2024 | 3093 | 0.710 |
Why?
|
| Behavioral Symptoms | 3 | 2020 | 186 | 0.700 |
Why?
|
| Obsessive-Compulsive Disorder | 4 | 2024 | 1491 | 0.700 |
Why?
|
| Models, Theoretical | 4 | 2021 | 3575 | 0.700 |
Why?
|
| Patient Discharge | 5 | 2024 | 3443 | 0.690 |
Why?
|
| Work | 5 | 2006 | 195 | 0.690 |
Why?
|
| Occupational Health | 7 | 2008 | 806 | 0.690 |
Why?
|
| Europe | 24 | 2024 | 3420 | 0.680 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 10 | 2016 | 303 | 0.680 |
Why?
|
| Role | 4 | 2009 | 176 | 0.680 |
Why?
|
| Irritable Mood | 2 | 2013 | 194 | 0.680 |
Why?
|
| Lung Transplantation | 8 | 2024 | 1310 | 0.670 |
Why?
|
| Child | 93 | 2023 | 80157 | 0.670 |
Why?
|
| Divorce | 5 | 2011 | 75 | 0.660 |
Why?
|
| Decision Support Systems, Clinical | 3 | 2019 | 1175 | 0.660 |
Why?
|
| Regression Analysis | 28 | 2016 | 6344 | 0.660 |
Why?
|
| Employer Health Costs | 4 | 2008 | 21 | 0.650 |
Why?
|
| Social Adjustment | 7 | 2017 | 632 | 0.650 |
Why?
|
| Epidemiologic Studies | 8 | 2018 | 675 | 0.640 |
Why?
|
| Family Health | 8 | 2012 | 1257 | 0.640 |
Why?
|
| Prognosis | 33 | 2024 | 29629 | 0.640 |
Why?
|
| Genome-Wide Association Study | 26 | 2024 | 12690 | 0.630 |
Why?
|
| Psychiatry | 11 | 2021 | 1693 | 0.630 |
Why?
|
| Interpersonal Relations | 16 | 2019 | 1436 | 0.620 |
Why?
|
| Argentina | 8 | 2019 | 246 | 0.620 |
Why?
|
| Self-Assessment | 6 | 2017 | 397 | 0.620 |
Why?
|
| Ambulatory Care | 10 | 2012 | 2775 | 0.620 |
Why?
|
| Health Status Indicators | 7 | 2012 | 970 | 0.610 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 9 | 2019 | 3204 | 0.600 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2021 | 942 | 0.600 |
Why?
|
| Community Mental Health Services | 8 | 2011 | 392 | 0.580 |
Why?
|
| Hallucinations | 3 | 2018 | 366 | 0.580 |
Why?
|
| Cohort Studies | 60 | 2024 | 41493 | 0.580 |
Why?
|
| Social Conditions | 5 | 2012 | 120 | 0.580 |
Why?
|
| Outpatients | 4 | 2022 | 1597 | 0.580 |
Why?
|
| Health Services Research | 11 | 2018 | 1812 | 0.580 |
Why?
|
| Hemoglobinopathies | 1 | 2018 | 99 | 0.570 |
Why?
|
| Pulmonary Medicine | 5 | 2017 | 221 | 0.570 |
Why?
|
| Post-Concussion Syndrome | 3 | 2019 | 243 | 0.570 |
Why?
|
| Blood Gas Analysis | 2 | 2018 | 379 | 0.570 |
Why?
|
| Electronic Health Records | 3 | 2024 | 4811 | 0.560 |
Why?
|
| France | 13 | 2024 | 497 | 0.550 |
Why?
|
| Bulimia | 8 | 2013 | 400 | 0.550 |
Why?
|
| Therapy, Computer-Assisted | 4 | 2019 | 266 | 0.550 |
Why?
|
| Delusions | 2 | 2018 | 298 | 0.550 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 5 | 2011 | 306 | 0.550 |
Why?
|
| Sex Distribution | 14 | 2019 | 2280 | 0.540 |
Why?
|
| Personality Assessment | 14 | 2012 | 650 | 0.540 |
Why?
|
| Survivors | 11 | 2024 | 2371 | 0.540 |
Why?
|
| Belgium | 11 | 2021 | 118 | 0.530 |
Why?
|
| Schizophrenia | 18 | 2023 | 6937 | 0.530 |
Why?
|
| Dissociative Disorders | 2 | 2022 | 234 | 0.530 |
Why?
|
| Americas | 7 | 2016 | 111 | 0.520 |
Why?
|
| Firesetting Behavior | 1 | 2015 | 5 | 0.520 |
Why?
|
| Cell-Derived Microparticles | 1 | 2017 | 161 | 0.520 |
Why?
|
| Binge-Eating Disorder | 2 | 2019 | 147 | 0.520 |
Why?
|
| Inpatients | 2 | 2024 | 2548 | 0.520 |
Why?
|
| Sleep Apnea Syndromes | 9 | 2020 | 975 | 0.520 |
Why?
|
| School Health Services | 3 | 2015 | 384 | 0.520 |
Why?
|
| Personality Disorders | 5 | 2009 | 722 | 0.510 |
Why?
|
| Earthquakes | 2 | 2019 | 191 | 0.510 |
Why?
|
| Parents | 17 | 2024 | 3563 | 0.510 |
Why?
|
| Psychophysiologic Disorders | 6 | 2008 | 221 | 0.510 |
Why?
|
| Probability | 19 | 2009 | 2477 | 0.510 |
Why?
|
| Treatment Outcome | 42 | 2024 | 64684 | 0.500 |
Why?
|
| Area Under Curve | 8 | 2017 | 1638 | 0.500 |
Why?
|
| New Zealand | 7 | 2019 | 358 | 0.500 |
Why?
|
| Bronchodilator Agents | 2 | 2017 | 512 | 0.500 |
Why?
|
| Aged, 80 and over | 50 | 2020 | 58983 | 0.500 |
Why?
|
| Social Support | 24 | 2021 | 2171 | 0.490 |
Why?
|
| South Africa | 13 | 2024 | 1843 | 0.490 |
Why?
|
| Occupations | 9 | 2017 | 515 | 0.490 |
Why?
|
| Drug Tolerance | 1 | 2017 | 367 | 0.490 |
Why?
|
| Factor Analysis, Statistical | 9 | 2019 | 999 | 0.490 |
Why?
|
| Respiration Disorders | 2 | 2017 | 367 | 0.480 |
Why?
|
| Oximetry | 1 | 2018 | 459 | 0.480 |
Why?
|
| Task Performance and Analysis | 3 | 2008 | 763 | 0.480 |
Why?
|
| Diabetic Neuropathies | 2 | 2017 | 405 | 0.470 |
Why?
|
| Chi-Square Distribution | 14 | 2013 | 3415 | 0.470 |
Why?
|
| Databases, Factual | 11 | 2021 | 7967 | 0.470 |
Why?
|
| Personality Inventory | 13 | 2014 | 1019 | 0.470 |
Why?
|
| Adolescent Health Services | 2 | 2014 | 218 | 0.460 |
Why?
|
| Cost-Benefit Analysis | 12 | 2021 | 5492 | 0.460 |
Why?
|
| Twins, Dizygotic | 30 | 2000 | 236 | 0.460 |
Why?
|
| Drug Therapy | 2 | 2007 | 503 | 0.460 |
Why?
|
| Qatar | 5 | 2024 | 40 | 0.450 |
Why?
|
| Emigration and Immigration | 2 | 2007 | 397 | 0.450 |
Why?
|
| Drug Users | 2 | 2019 | 134 | 0.450 |
Why?
|
| Delivery of Health Care | 14 | 2021 | 5336 | 0.450 |
Why?
|
| Latin America | 6 | 2023 | 410 | 0.450 |
Why?
|
| Disease Progression | 15 | 2020 | 13510 | 0.450 |
Why?
|
| International Cooperation | 13 | 2015 | 1422 | 0.440 |
Why?
|
| Healthcare Disparities | 8 | 2024 | 3358 | 0.440 |
Why?
|
| Quality of Life | 16 | 2022 | 13367 | 0.430 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 5 | 2017 | 515 | 0.430 |
Why?
|
| Pain | 9 | 2023 | 5073 | 0.430 |
Why?
|
| Survival Analysis | 26 | 2015 | 10090 | 0.430 |
Why?
|
| Achievement | 3 | 2017 | 288 | 0.420 |
Why?
|
| Family Relations | 4 | 2013 | 317 | 0.420 |
Why?
|
| Checklist | 2 | 2019 | 827 | 0.420 |
Why?
|
| Twins, Monozygotic | 30 | 2000 | 470 | 0.420 |
Why?
|
| Lebanon | 5 | 2019 | 245 | 0.410 |
Why?
|
| Homicide | 1 | 2015 | 294 | 0.410 |
Why?
|
| Educational Measurement | 2 | 2016 | 1255 | 0.410 |
Why?
|
| Child, Preschool | 30 | 2022 | 42231 | 0.410 |
Why?
|
| Unemployment | 8 | 2018 | 210 | 0.400 |
Why?
|
| Stress Disorders, Traumatic, Acute | 1 | 2012 | 28 | 0.400 |
Why?
|
| Statistics as Topic | 14 | 2017 | 2358 | 0.400 |
Why?
|
| Home Nursing | 1 | 2012 | 92 | 0.400 |
Why?
|
| Emigrants and Immigrants | 1 | 2018 | 543 | 0.400 |
Why?
|
| Homosexuality | 10 | 2000 | 267 | 0.400 |
Why?
|
| Widowhood | 3 | 2001 | 51 | 0.400 |
Why?
|
| Afghanistan | 3 | 2021 | 78 | 0.390 |
Why?
|
| Randomized Controlled Trials as Topic | 9 | 2024 | 10212 | 0.390 |
Why?
|
| Peptic Ulcer | 1 | 2013 | 217 | 0.390 |
Why?
|
| Cluster Analysis | 8 | 2018 | 2707 | 0.390 |
Why?
|
| Heart Diseases | 5 | 2017 | 2781 | 0.380 |
Why?
|
| Spouse Abuse | 2 | 2011 | 182 | 0.380 |
Why?
|
| Refugees | 2 | 2019 | 596 | 0.380 |
Why?
|
| Vulnerable Populations | 1 | 2017 | 703 | 0.380 |
Why?
|
| Health Policy | 10 | 2015 | 2684 | 0.380 |
Why?
|
| Efficiency, Organizational | 4 | 2009 | 695 | 0.380 |
Why?
|
| Iraq | 4 | 2021 | 92 | 0.380 |
Why?
|
| Arthritis | 4 | 2016 | 680 | 0.370 |
Why?
|
| Courtship | 1 | 2011 | 34 | 0.370 |
Why?
|
| Grief | 3 | 2011 | 254 | 0.370 |
Why?
|
| Insurance, Pharmaceutical Services | 2 | 2007 | 348 | 0.370 |
Why?
|
| Minority Groups | 3 | 2020 | 1203 | 0.370 |
Why?
|
| Student Dropouts | 2 | 2009 | 27 | 0.360 |
Why?
|
| Bulimia Nervosa | 1 | 2013 | 206 | 0.360 |
Why?
|
| Genetic Predisposition to Disease | 25 | 2024 | 17904 | 0.360 |
Why?
|
| Student Health Services | 3 | 2019 | 40 | 0.360 |
Why?
|
| Oxygen | 9 | 2018 | 4227 | 0.360 |
Why?
|
| Caregivers | 2 | 2013 | 2238 | 0.350 |
Why?
|
| Mexico | 7 | 2019 | 764 | 0.350 |
Why?
|
| Respiratory Insufficiency | 2 | 2018 | 1230 | 0.350 |
Why?
|
| Crime | 6 | 2015 | 203 | 0.350 |
Why?
|
| Population Dynamics | 1 | 2012 | 307 | 0.350 |
Why?
|
| Floods | 1 | 2010 | 41 | 0.350 |
Why?
|
| Spouses | 2 | 2019 | 283 | 0.350 |
Why?
|
| Multivariate Analysis | 23 | 2017 | 12059 | 0.350 |
Why?
|
| Germany | 11 | 2017 | 875 | 0.350 |
Why?
|
| Headache Disorders | 2 | 2014 | 152 | 0.350 |
Why?
|
| Causality | 15 | 2017 | 1242 | 0.340 |
Why?
|
| Aftercare | 3 | 2023 | 914 | 0.340 |
Why?
|
| Veterans Health | 2 | 2021 | 215 | 0.330 |
Why?
|
| Pleurisy | 1 | 2009 | 54 | 0.330 |
Why?
|
| Louisiana | 5 | 2011 | 103 | 0.330 |
Why?
|
| Community Health Planning | 1 | 2010 | 164 | 0.330 |
Why?
|
| Physician-Patient Relations | 4 | 2022 | 3249 | 0.330 |
Why?
|
| Emergency Service, Hospital | 8 | 2022 | 7879 | 0.330 |
Why?
|
| Diabetic Angiopathies | 1 | 2014 | 803 | 0.330 |
Why?
|
| Lung Diseases | 6 | 2020 | 1909 | 0.330 |
Why?
|
| Incidence | 35 | 2022 | 21355 | 0.330 |
Why?
|
| Familial Mediterranean Fever | 1 | 2009 | 65 | 0.320 |
Why?
|
| Asia | 6 | 2016 | 619 | 0.320 |
Why?
|
| Case-Control Studies | 26 | 2023 | 22176 | 0.320 |
Why?
|
| Acculturation | 2 | 2007 | 178 | 0.320 |
Why?
|
| Sensitivity and Specificity | 13 | 2021 | 14665 | 0.320 |
Why?
|
| Data Mining | 1 | 2014 | 551 | 0.320 |
Why?
|
| Tissue Donors | 2 | 2024 | 2332 | 0.310 |
Why?
|
| Executive Function | 2 | 2017 | 1392 | 0.310 |
Why?
|
| Telemedicine | 2 | 2023 | 3052 | 0.310 |
Why?
|
| Peanut Hypersensitivity | 1 | 2011 | 219 | 0.310 |
Why?
|
| Cannabis | 5 | 2024 | 441 | 0.310 |
Why?
|
| DNA Methylation | 6 | 2024 | 4399 | 0.310 |
Why?
|
| Psychomotor Agitation | 1 | 2011 | 305 | 0.310 |
Why?
|
| Multifactorial Inheritance | 7 | 2023 | 1387 | 0.300 |
Why?
|
| Peritonsillar Abscess | 1 | 2008 | 18 | 0.300 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 2008 | 107 | 0.300 |
Why?
|
| Models, Economic | 2 | 2012 | 716 | 0.300 |
Why?
|
| Recurrence | 14 | 2023 | 8466 | 0.300 |
Why?
|
| Intention | 2 | 2023 | 347 | 0.300 |
Why?
|
| Patient Advocacy | 2 | 2000 | 360 | 0.300 |
Why?
|
| Albuminuria | 1 | 2012 | 658 | 0.300 |
Why?
|
| Bullying | 3 | 2021 | 232 | 0.300 |
Why?
|
| Brain Concussion | 2 | 2016 | 1404 | 0.290 |
Why?
|
| Fantasy | 1 | 2007 | 69 | 0.290 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 2 | 2019 | 324 | 0.290 |
Why?
|
| Diagnosis, Differential | 18 | 2019 | 12973 | 0.290 |
Why?
|
| Patient Selection | 3 | 2019 | 4244 | 0.290 |
Why?
|
| Patient Compliance | 4 | 2020 | 2690 | 0.290 |
Why?
|
| Research Design | 14 | 2018 | 6180 | 0.290 |
Why?
|
| Bereavement | 4 | 2010 | 308 | 0.290 |
Why?
|
| Wrist | 3 | 2024 | 227 | 0.280 |
Why?
|
| Gender Identity | 5 | 2009 | 766 | 0.280 |
Why?
|
| Foster Home Care | 1 | 2008 | 133 | 0.280 |
Why?
|
| Recovery of Function | 1 | 2017 | 2979 | 0.280 |
Why?
|
| Family Practice | 2 | 2006 | 512 | 0.280 |
Why?
|
| Poland | 3 | 2018 | 198 | 0.280 |
Why?
|
| Epidemiology | 2 | 2000 | 279 | 0.270 |
Why?
|
| Food Supply | 1 | 2012 | 544 | 0.270 |
Why?
|
| Specialization | 2 | 2014 | 778 | 0.270 |
Why?
|
| United States Department of Defense | 5 | 2021 | 34 | 0.270 |
Why?
|
| Attitude to Death | 2 | 2021 | 400 | 0.270 |
Why?
|
| Pleural Effusion | 1 | 2009 | 341 | 0.270 |
Why?
|
| Multilingualism | 1 | 2007 | 87 | 0.260 |
Why?
|
| Industry | 2 | 2008 | 364 | 0.260 |
Why?
|
| Mexican Americans | 1 | 2007 | 167 | 0.260 |
Why?
|
| Genetic Loci | 6 | 2024 | 2632 | 0.260 |
Why?
|
| Commerce | 2 | 2009 | 606 | 0.260 |
Why?
|
| Attitude | 6 | 2007 | 775 | 0.260 |
Why?
|
| Prescription Fees | 1 | 2007 | 153 | 0.260 |
Why?
|
| Community-Institutional Relations | 1 | 2007 | 206 | 0.260 |
Why?
|
| Public Health | 6 | 2019 | 2669 | 0.260 |
Why?
|
| Insurance Claim Reporting | 1 | 2006 | 166 | 0.260 |
Why?
|
| Cohort Effect | 6 | 2006 | 39 | 0.260 |
Why?
|
| Health Services Misuse | 1 | 2007 | 244 | 0.250 |
Why?
|
| Combined Modality Therapy | 10 | 2023 | 8528 | 0.250 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 7391 | 0.250 |
Why?
|
| Health Personnel | 8 | 2024 | 3335 | 0.250 |
Why?
|
| Managed Care Programs | 3 | 2007 | 940 | 0.250 |
Why?
|
| Costs and Cost Analysis | 9 | 2010 | 1668 | 0.250 |
Why?
|
| Self Psychology | 1 | 2005 | 8 | 0.250 |
Why?
|
| Risk-Taking | 4 | 2022 | 1038 | 0.250 |
Why?
|
| Insurance, Health | 6 | 2013 | 2498 | 0.250 |
Why?
|
| Australia | 6 | 2020 | 1250 | 0.250 |
Why?
|
| Hypnotics and Sedatives | 1 | 2013 | 1179 | 0.250 |
Why?
|
| Confidence Intervals | 10 | 2003 | 2927 | 0.250 |
Why?
|
| Pandemics | 11 | 2024 | 8656 | 0.240 |
Why?
|
| Health Promotion | 5 | 2021 | 2214 | 0.240 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2014 | 1875 | 0.240 |
Why?
|
| Antipsychotic Agents | 6 | 2020 | 3067 | 0.240 |
Why?
|
| Algorithms | 12 | 2023 | 14032 | 0.240 |
Why?
|
| Polymorphism, Single Nucleotide | 16 | 2024 | 15936 | 0.240 |
Why?
|
| Neck Pain | 3 | 2017 | 190 | 0.240 |
Why?
|
| Personality | 9 | 2022 | 554 | 0.230 |
Why?
|
| Gambling | 1 | 2008 | 258 | 0.230 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2020 | 1136 | 0.230 |
Why?
|
| Research | 7 | 2010 | 1982 | 0.230 |
Why?
|
| Tomography, Emission-Computed | 12 | 1996 | 1122 | 0.230 |
Why?
|
| Brazil | 8 | 2022 | 1230 | 0.230 |
Why?
|
| Hypertension, Pulmonary | 8 | 2005 | 1578 | 0.230 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2017 | 3415 | 0.220 |
Why?
|
| Bisexuality | 3 | 2022 | 294 | 0.220 |
Why?
|
| Personality Development | 6 | 2011 | 244 | 0.220 |
Why?
|
| Predictive Value of Tests | 12 | 2016 | 15266 | 0.220 |
Why?
|
| Obesity Hypoventilation Syndrome | 2 | 2010 | 17 | 0.220 |
Why?
|
| Object Attachment | 3 | 2023 | 326 | 0.220 |
Why?
|
| Japan | 5 | 2017 | 1378 | 0.210 |
Why?
|
| Heart Rate | 3 | 2024 | 4195 | 0.210 |
Why?
|
| Students, Medical | 1 | 2016 | 1936 | 0.210 |
Why?
|
| Neck | 1 | 2008 | 734 | 0.210 |
Why?
|
| Curriculum | 1 | 2016 | 3743 | 0.210 |
Why?
|
| Sociology | 1 | 2002 | 21 | 0.210 |
Why?
|
| Radiology | 1 | 2016 | 2113 | 0.200 |
Why?
|
| Social Welfare | 3 | 2000 | 87 | 0.200 |
Why?
|
| Social Problems | 1 | 2023 | 109 | 0.200 |
Why?
|
| Back Pain | 3 | 2017 | 545 | 0.200 |
Why?
|
| Smoking Cessation | 3 | 2009 | 2057 | 0.200 |
Why?
|
| Ontario | 8 | 2002 | 398 | 0.200 |
Why?
|
| Clergy | 1 | 2003 | 79 | 0.200 |
Why?
|
| Primary Health Care | 8 | 2022 | 4686 | 0.200 |
Why?
|
| Internal Capsule | 1 | 2023 | 138 | 0.200 |
Why?
|
| Marijuana Smoking | 2 | 2019 | 258 | 0.200 |
Why?
|
| Self Concept | 7 | 2018 | 1045 | 0.200 |
Why?
|
| Education | 5 | 2007 | 537 | 0.200 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2005 | 432 | 0.190 |
Why?
|
| Women | 3 | 1998 | 223 | 0.190 |
Why?
|
| Seasons | 1 | 2007 | 1520 | 0.190 |
Why?
|
| Pollen | 1 | 2001 | 80 | 0.190 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2001 | 59 | 0.190 |
Why?
|
| Schools | 7 | 2015 | 1489 | 0.190 |
Why?
|
| Social Stigma | 3 | 2018 | 769 | 0.190 |
Why?
|
| Referral and Consultation | 5 | 2012 | 3600 | 0.190 |
Why?
|
| Dreams | 1 | 2022 | 146 | 0.190 |
Why?
|
| Nuclear Family | 1 | 2002 | 311 | 0.180 |
Why?
|
| Sexual Behavior | 9 | 2022 | 2180 | 0.180 |
Why?
|
| Repressor Proteins | 3 | 2020 | 2986 | 0.180 |
Why?
|
| Somatoform Disorders | 6 | 2010 | 423 | 0.180 |
Why?
|
| Pneumonectomy | 9 | 2004 | 1119 | 0.180 |
Why?
|
| Headache | 1 | 2009 | 1256 | 0.180 |
Why?
|
| Emotions | 5 | 2022 | 2739 | 0.180 |
Why?
|
| Polysomnography | 6 | 2014 | 1848 | 0.180 |
Why?
|
| Cities | 4 | 2019 | 546 | 0.180 |
Why?
|
| New Orleans | 2 | 2010 | 27 | 0.180 |
Why?
|
| Telephone | 4 | 2012 | 627 | 0.180 |
Why?
|
| Colonic Diseases, Functional | 1 | 2000 | 39 | 0.180 |
Why?
|
| Child Rearing | 4 | 1997 | 73 | 0.180 |
Why?
|
| Psychotherapy, Group | 1 | 2024 | 412 | 0.180 |
Why?
|
| Health Services | 4 | 2024 | 752 | 0.180 |
Why?
|
| Workers' Compensation | 1 | 2001 | 150 | 0.170 |
Why?
|
| Obesity | 8 | 2020 | 12947 | 0.170 |
Why?
|
| Migraine Disorders | 2 | 2010 | 1703 | 0.170 |
Why?
|
| Occupational Health Services | 2 | 2014 | 150 | 0.170 |
Why?
|
| Blood Pressure | 6 | 2024 | 8481 | 0.170 |
Why?
|
| Insurance, Psychiatric | 4 | 2009 | 69 | 0.170 |
Why?
|
| Occupational Exposure | 2 | 2008 | 1813 | 0.170 |
Why?
|
| Africa | 3 | 2017 | 709 | 0.170 |
Why?
|
| Oxygen Inhalation Therapy | 3 | 2020 | 411 | 0.170 |
Why?
|
| Affect | 2 | 2023 | 1486 | 0.160 |
Why?
|
| Sick Role | 5 | 2007 | 229 | 0.160 |
Why?
|
| Homosexuality, Female | 1 | 2001 | 171 | 0.160 |
Why?
|
| Osteoarthritis | 1 | 2007 | 1063 | 0.160 |
Why?
|
| Sulfotransferases | 1 | 2020 | 150 | 0.160 |
Why?
|
| Population | 2 | 2012 | 141 | 0.160 |
Why?
|
| Nigeria | 3 | 2023 | 770 | 0.160 |
Why?
|
| Psychotherapy, Brief | 1 | 2020 | 118 | 0.160 |
Why?
|
| Rape | 1 | 2019 | 131 | 0.160 |
Why?
|
| Antisocial Personality Disorder | 2 | 1997 | 224 | 0.160 |
Why?
|
| Environment | 4 | 2019 | 1123 | 0.160 |
Why?
|
| Syria | 1 | 2019 | 85 | 0.160 |
Why?
|
| Social Responsibility | 1 | 2021 | 386 | 0.160 |
Why?
|
| Fungi | 1 | 2001 | 338 | 0.160 |
Why?
|
| Online Systems | 1 | 2019 | 182 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2024 | 36426 | 0.160 |
Why?
|
| Terminology as Topic | 9 | 2007 | 1530 | 0.160 |
Why?
|
| Medicine | 2 | 2006 | 942 | 0.160 |
Why?
|
| Netherlands | 6 | 2023 | 2221 | 0.150 |
Why?
|
| Cardiovascular Diseases | 7 | 2020 | 15502 | 0.150 |
Why?
|
| Emergency Medical Services | 2 | 2020 | 1923 | 0.150 |
Why?
|
| Men | 1 | 1998 | 65 | 0.150 |
Why?
|
| Acquired Immunodeficiency Syndrome | 11 | 2010 | 2199 | 0.150 |
Why?
|
| Single Person | 3 | 1998 | 31 | 0.150 |
Why?
|
| Child Abuse, Sexual | 1 | 2001 | 403 | 0.150 |
Why?
|
| Illegitimacy | 1 | 1997 | 4 | 0.150 |
Why?
|
| Respiratory Paralysis | 2 | 2016 | 32 | 0.150 |
Why?
|
| Hypnosis | 1 | 1998 | 82 | 0.150 |
Why?
|
| Disaster Planning | 3 | 2009 | 557 | 0.150 |
Why?
|
| Positive-Pressure Respiration | 2 | 1999 | 639 | 0.150 |
Why?
|
| Brain | 18 | 2024 | 27121 | 0.150 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2019 | 123 | 0.150 |
Why?
|
| Rectum | 3 | 2005 | 892 | 0.150 |
Why?
|
| Behavior | 2 | 2019 | 541 | 0.150 |
Why?
|
| Reward | 1 | 2024 | 971 | 0.150 |
Why?
|
| Quality of Health Care | 7 | 2019 | 4330 | 0.140 |
Why?
|
| California | 4 | 2007 | 1430 | 0.140 |
Why?
|
| Precipitating Factors | 2 | 2021 | 51 | 0.140 |
Why?
|
| Opportunistic Infections | 1 | 2020 | 376 | 0.140 |
Why?
|
| Michigan | 10 | 1999 | 339 | 0.140 |
Why?
|
| World War II | 1 | 2017 | 61 | 0.140 |
Why?
|
| Bayes Theorem | 4 | 2023 | 2330 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 5 | 2020 | 7406 | 0.140 |
Why?
|
| Trauma Severity Indices | 4 | 2021 | 478 | 0.140 |
Why?
|
| Explosive Agents | 1 | 2017 | 26 | 0.140 |
Why?
|
| Behavior, Addictive | 2 | 2008 | 462 | 0.140 |
Why?
|
| Respiratory Tract Diseases | 2 | 2017 | 750 | 0.140 |
Why?
|
| Disease Susceptibility | 3 | 2021 | 1787 | 0.140 |
Why?
|
| Cognition | 5 | 2022 | 6992 | 0.140 |
Why?
|
| Data Interpretation, Statistical | 5 | 2024 | 2691 | 0.140 |
Why?
|
| Hospitalization | 7 | 2024 | 10721 | 0.140 |
Why?
|
| Cholestanols | 1 | 2016 | 8 | 0.140 |
Why?
|
| Filipin | 1 | 2016 | 13 | 0.140 |
Why?
|
| Drug Therapy, Combination | 4 | 2020 | 6312 | 0.140 |
Why?
|
| Peer Group | 4 | 2019 | 692 | 0.140 |
Why?
|
| Hexosaminidases | 1 | 2016 | 45 | 0.140 |
Why?
|
| Airway Obstruction | 2 | 2020 | 661 | 0.140 |
Why?
|
| United States Substance Abuse and Mental Health Services Administration | 2 | 2008 | 21 | 0.140 |
Why?
|
| Airway Management | 1 | 2020 | 312 | 0.130 |
Why?
|
| Translating | 3 | 2014 | 143 | 0.130 |
Why?
|
| Infant | 14 | 2019 | 36193 | 0.130 |
Why?
|
| Epigenesis, Genetic | 5 | 2022 | 3801 | 0.130 |
Why?
|
| Awareness | 1 | 2000 | 648 | 0.130 |
Why?
|
| Pilot Projects | 7 | 2021 | 8633 | 0.130 |
Why?
|
| Vasodilator Agents | 1 | 2020 | 973 | 0.130 |
Why?
|
| Television | 2 | 1989 | 408 | 0.130 |
Why?
|
| Internship and Residency | 1 | 2016 | 5882 | 0.130 |
Why?
|
| Niemann-Pick Disease, Type C | 1 | 2016 | 49 | 0.130 |
Why?
|
| Pregnancy in Adolescence | 1 | 1997 | 163 | 0.130 |
Why?
|
| Self Care | 3 | 2019 | 796 | 0.130 |
Why?
|
| Middle East | 1 | 2016 | 231 | 0.130 |
Why?
|
| Receptors, CCR2 | 1 | 2017 | 215 | 0.130 |
Why?
|
| Homosexuality, Male | 2 | 2001 | 1334 | 0.130 |
Why?
|
| Epilepsy | 1 | 2011 | 3290 | 0.130 |
Why?
|
| Psychotropic Drugs | 4 | 2007 | 888 | 0.130 |
Why?
|
| Selection Bias | 1 | 1997 | 359 | 0.130 |
Why?
|
| Propensity Score | 3 | 2019 | 1913 | 0.130 |
Why?
|
| Sex Characteristics | 2 | 2024 | 2639 | 0.130 |
Why?
|
| Morbidity | 5 | 2011 | 1751 | 0.120 |
Why?
|
| Autopsy | 1 | 2019 | 1009 | 0.120 |
Why?
|
| Pulmonary Gas Exchange | 4 | 2005 | 379 | 0.120 |
Why?
|
| Immunocompromised Host | 2 | 2018 | 858 | 0.120 |
Why?
|
| Time | 1 | 2017 | 546 | 0.120 |
Why?
|
| Prejudice | 1 | 1999 | 570 | 0.120 |
Why?
|
| Penile Prosthesis | 2 | 1994 | 32 | 0.120 |
Why?
|
| CpG Islands | 1 | 2020 | 1230 | 0.120 |
Why?
|
| Forced Expiratory Volume | 4 | 2013 | 1814 | 0.120 |
Why?
|
| Insurance Coverage | 3 | 2012 | 1940 | 0.120 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2017 | 269 | 0.120 |
Why?
|
| Commitment of Mentally Ill | 1 | 2015 | 94 | 0.120 |
Why?
|
| Blood Glucose | 8 | 2013 | 6391 | 0.120 |
Why?
|
| Early Diagnosis | 4 | 2019 | 1186 | 0.120 |
Why?
|
| Economic Recession | 1 | 2015 | 79 | 0.120 |
Why?
|
| Disease | 1 | 2020 | 672 | 0.120 |
Why?
|
| Religion | 1 | 2018 | 372 | 0.120 |
Why?
|
| Cocaine-Related Disorders | 2 | 2008 | 461 | 0.120 |
Why?
|
| Terrorism | 1 | 2017 | 211 | 0.110 |
Why?
|
| Aging | 4 | 2019 | 8711 | 0.110 |
Why?
|
| Proportional Hazards Models | 8 | 2020 | 12463 | 0.110 |
Why?
|
| Hospitals, Psychiatric | 2 | 2024 | 321 | 0.110 |
Why?
|
| Switzerland | 3 | 2012 | 324 | 0.110 |
Why?
|
| Patient Preference | 1 | 2021 | 924 | 0.110 |
Why?
|
| Bronchoscopy | 1 | 2020 | 909 | 0.110 |
Why?
|
| Colombia | 3 | 2019 | 282 | 0.110 |
Why?
|
| Dibenzocycloheptenes | 1 | 2013 | 27 | 0.110 |
Why?
|
| Cephalosporins | 1 | 1995 | 198 | 0.110 |
Why?
|
| Delayed Diagnosis | 1 | 2018 | 463 | 0.110 |
Why?
|
| Occupational Medicine | 1 | 2014 | 114 | 0.110 |
Why?
|
| Pruritus | 1 | 2017 | 380 | 0.110 |
Why?
|
| Allergens | 1 | 2001 | 1432 | 0.110 |
Why?
|
| Counseling | 4 | 2022 | 1547 | 0.110 |
Why?
|
| Thrombosis | 1 | 2008 | 2942 | 0.110 |
Why?
|
| Pulmonary Circulation | 5 | 1999 | 737 | 0.110 |
Why?
|
| Respiratory Function Tests | 7 | 2013 | 1682 | 0.110 |
Why?
|
| DNA Copy Number Variations | 1 | 2022 | 2020 | 0.110 |
Why?
|
| Penicillium chrysogenum | 1 | 2013 | 7 | 0.110 |
Why?
|
| Information Storage and Retrieval | 1 | 2019 | 819 | 0.110 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2017 | 632 | 0.110 |
Why?
|
| Health Behavior | 2 | 2007 | 2644 | 0.110 |
Why?
|
| Poverty Areas | 2 | 2011 | 263 | 0.110 |
Why?
|
| Public Policy | 3 | 2014 | 559 | 0.110 |
Why?
|
| Linear Models | 4 | 2019 | 5872 | 0.110 |
Why?
|
| Behavioral Research | 2 | 2016 | 52 | 0.110 |
Why?
|
| Analysis of Variance | 6 | 2010 | 6228 | 0.110 |
Why?
|
| Patient Satisfaction | 3 | 2020 | 3461 | 0.110 |
Why?
|
| Feeding Behavior | 4 | 2008 | 3188 | 0.110 |
Why?
|
| Information Services | 1 | 2014 | 236 | 0.110 |
Why?
|
| Fruit | 2 | 1995 | 1160 | 0.100 |
Why?
|
| Streptomyces | 1 | 2013 | 91 | 0.100 |
Why?
|
| Vegetables | 2 | 1995 | 1195 | 0.100 |
Why?
|
| Virginia | 11 | 1997 | 116 | 0.100 |
Why?
|
| Cystic Fibrosis | 2 | 2013 | 1285 | 0.100 |
Why?
|
| Death | 2 | 2016 | 676 | 0.100 |
Why?
|
| Genotype | 7 | 2019 | 12990 | 0.100 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 2013 | 63 | 0.100 |
Why?
|
| Motivation | 3 | 2019 | 2006 | 0.100 |
Why?
|
| Environmental Exposure | 1 | 2007 | 4485 | 0.100 |
Why?
|
| Alcoholic Beverages | 1 | 2014 | 264 | 0.100 |
Why?
|
| Models, Genetic | 25 | 1996 | 3442 | 0.100 |
Why?
|
| Personal Satisfaction | 2 | 2017 | 644 | 0.100 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2023 | 2400 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3206 | 0.100 |
Why?
|
| Military Medicine | 1 | 2014 | 184 | 0.100 |
Why?
|
| Blast Injuries | 1 | 2016 | 322 | 0.100 |
Why?
|
| Parent-Child Relations | 3 | 2010 | 761 | 0.100 |
Why?
|
| Polymorphism, Genetic | 2 | 2019 | 4243 | 0.100 |
Why?
|
| Transplantation, Autologous | 1 | 2017 | 2115 | 0.100 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2008 | 3763 | 0.100 |
Why?
|
| Program Evaluation | 3 | 2015 | 2495 | 0.100 |
Why?
|
| Colchicine | 2 | 2013 | 259 | 0.100 |
Why?
|
| Workload | 3 | 2004 | 844 | 0.100 |
Why?
|
| Intradermal Tests | 1 | 2011 | 42 | 0.100 |
Why?
|
| Nocardia asteroides | 1 | 1991 | 9 | 0.100 |
Why?
|
| Lung Neoplasms | 11 | 2005 | 13382 | 0.100 |
Why?
|
| Hypertension | 6 | 2020 | 8540 | 0.100 |
Why?
|
| Vasovasostomy | 1 | 1991 | 6 | 0.100 |
Why?
|
| Nocardia Infections | 1 | 1991 | 19 | 0.100 |
Why?
|
| Vitamin D Deficiency | 1 | 2021 | 1388 | 0.100 |
Why?
|
| Drug Approval | 1 | 1999 | 814 | 0.100 |
Why?
|
| Respiratory Mechanics | 1 | 1996 | 699 | 0.100 |
Why?
|
| Staining and Labeling | 1 | 2016 | 1085 | 0.100 |
Why?
|
| Pericarditis, Constrictive | 1 | 1991 | 46 | 0.100 |
Why?
|
| Calibration | 2 | 2005 | 818 | 0.100 |
Why?
|
| Cell Cycle Proteins | 2 | 2020 | 3449 | 0.100 |
Why?
|
| Partial Pressure | 3 | 2001 | 245 | 0.100 |
Why?
|
| Medicaid | 3 | 2006 | 2818 | 0.100 |
Why?
|
| Financing, Personal | 1 | 2014 | 309 | 0.090 |
Why?
|
| Physicians, Primary Care | 1 | 2018 | 623 | 0.090 |
Why?
|
| Phenotype | 11 | 2023 | 16592 | 0.090 |
Why?
|
| Body Mass Index | 6 | 2014 | 12953 | 0.090 |
Why?
|
| Syndrome | 3 | 2010 | 3267 | 0.090 |
Why?
|
| Pulmonary Artery | 3 | 1999 | 1927 | 0.090 |
Why?
|
| Happiness | 1 | 2012 | 170 | 0.090 |
Why?
|
| Penile Induration | 1 | 1991 | 16 | 0.090 |
Why?
|
| Peritoneal Diseases | 1 | 1991 | 75 | 0.090 |
Why?
|
| Irritable Bowel Syndrome | 2 | 2008 | 455 | 0.090 |
Why?
|
| Israel | 2 | 2019 | 726 | 0.090 |
Why?
|
| Respiratory System Agents | 1 | 2010 | 30 | 0.090 |
Why?
|
| Gram-Positive Bacteria | 1 | 1992 | 177 | 0.090 |
Why?
|
| Asthma | 4 | 2014 | 6234 | 0.090 |
Why?
|
| Naphthyridines | 1 | 1992 | 143 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 6 | 2005 | 5315 | 0.090 |
Why?
|
| Sick Leave | 2 | 2008 | 105 | 0.090 |
Why?
|
| Primary Graft Dysfunction | 2 | 2024 | 111 | 0.090 |
Why?
|
| Hernia, Diaphragmatic | 1 | 1991 | 245 | 0.090 |
Why?
|
| Computer Simulation | 3 | 2016 | 6241 | 0.090 |
Why?
|
| Health Expenditures | 6 | 2010 | 2366 | 0.090 |
Why?
|
| Health Planning | 1 | 2011 | 230 | 0.090 |
Why?
|
| Dysthymic Disorder | 2 | 2007 | 75 | 0.090 |
Why?
|
| Amygdala | 3 | 2023 | 1354 | 0.090 |
Why?
|
| Gram-Negative Bacteria | 1 | 1992 | 272 | 0.090 |
Why?
|
| Cause of Death | 3 | 2016 | 3683 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 1899 | 0.090 |
Why?
|
| Peritoneal Neoplasms | 1 | 2016 | 711 | 0.090 |
Why?
|
| Pain Measurement | 4 | 2017 | 3551 | 0.090 |
Why?
|
| Radiography, Thoracic | 4 | 2017 | 1302 | 0.080 |
Why?
|
| Mississippi | 1 | 2009 | 95 | 0.080 |
Why?
|
| Alabama | 1 | 2009 | 108 | 0.080 |
Why?
|
| Patient Care Team | 3 | 2013 | 2521 | 0.080 |
Why?
|
| Fluoroquinolones | 1 | 1992 | 307 | 0.080 |
Why?
|
| Cultural Characteristics | 1 | 2011 | 251 | 0.080 |
Why?
|
| HIV Seropositivity | 4 | 1993 | 960 | 0.080 |
Why?
|
| Postoperative Complications | 14 | 2018 | 15633 | 0.080 |
Why?
|
| Glucose Intolerance | 1 | 2013 | 575 | 0.080 |
Why?
|
| Women's Rights | 1 | 1989 | 65 | 0.080 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3086 | 0.080 |
Why?
|
| Safety Management | 1 | 2015 | 760 | 0.080 |
Why?
|
| Viruses | 1 | 2013 | 375 | 0.080 |
Why?
|
| Paternal Deprivation | 3 | 2010 | 10 | 0.080 |
Why?
|
| Capacity Building | 1 | 2011 | 258 | 0.080 |
Why?
|
| Tubulin Modulators | 1 | 2009 | 107 | 0.080 |
Why?
|
| Space-Time Clustering | 1 | 1988 | 45 | 0.080 |
Why?
|
| Family Conflict | 1 | 2009 | 95 | 0.080 |
Why?
|
| Evidence-Based Practice | 3 | 2017 | 495 | 0.080 |
Why?
|
| Italy | 1 | 2011 | 842 | 0.080 |
Why?
|
| Ventricular Pressure | 1 | 2010 | 210 | 0.080 |
Why?
|
| Child Care | 1 | 1989 | 124 | 0.080 |
Why?
|
| Vital Capacity | 4 | 2013 | 971 | 0.080 |
Why?
|
| Supine Position | 2 | 2000 | 205 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2016 | 11742 | 0.080 |
Why?
|
| Multilevel Analysis | 2 | 2019 | 150 | 0.080 |
Why?
|
| Diabetes Mellitus | 4 | 2020 | 5841 | 0.080 |
Why?
|
| Sleep | 6 | 2023 | 4768 | 0.080 |
Why?
|
| Reference Values | 3 | 2005 | 4920 | 0.080 |
Why?
|
| Cost Control | 3 | 2001 | 628 | 0.080 |
Why?
|
| Periodicity | 1 | 2010 | 348 | 0.080 |
Why?
|
| Psychological Theory | 2 | 2020 | 175 | 0.080 |
Why?
|
| Cetrimonium Compounds | 1 | 2008 | 4 | 0.080 |
Why?
|
| Myristates | 1 | 2008 | 12 | 0.080 |
Why?
|
| Maternal Deprivation | 3 | 2010 | 48 | 0.080 |
Why?
|
| Urbanization | 2 | 2019 | 100 | 0.080 |
Why?
|
| Simethicone | 1 | 2008 | 15 | 0.080 |
Why?
|
| Glycoproteins | 1 | 2016 | 2203 | 0.080 |
Why?
|
| Nicotinic Acids | 1 | 2008 | 31 | 0.080 |
Why?
|
| Chile | 3 | 2017 | 256 | 0.080 |
Why?
|
| Musculoskeletal Diseases | 2 | 2020 | 598 | 0.080 |
Why?
|
| Nepal | 2 | 2023 | 305 | 0.080 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2020 | 2155 | 0.080 |
Why?
|
| Stearic Acids | 1 | 2008 | 56 | 0.080 |
Why?
|
| Brain Mapping | 6 | 2005 | 6635 | 0.070 |
Why?
|
| Relief Work | 1 | 2009 | 131 | 0.070 |
Why?
|
| Stents | 1 | 2020 | 3179 | 0.070 |
Why?
|
| Ventricular Function | 1 | 2010 | 406 | 0.070 |
Why?
|
| Ambulatory Care Facilities | 1 | 2014 | 935 | 0.070 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 3688 | 0.070 |
Why?
|
| Infant Care | 2 | 2000 | 180 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 4176 | 0.070 |
Why?
|
| Nootropic Agents | 1 | 2008 | 157 | 0.070 |
Why?
|
| Housing | 1 | 2012 | 670 | 0.070 |
Why?
|
| Basal Ganglia | 3 | 1987 | 554 | 0.070 |
Why?
|
| Drug and Narcotic Control | 1 | 2008 | 144 | 0.070 |
Why?
|
| Washington | 1 | 2008 | 315 | 0.070 |
Why?
|
| Pedigree | 3 | 2009 | 4542 | 0.070 |
Why?
|
| Bioethical Issues | 1 | 2008 | 120 | 0.070 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 2164 | 0.070 |
Why?
|
| Registries | 14 | 2019 | 8224 | 0.070 |
Why?
|
| Bronchoalveolar Lavage | 2 | 2017 | 129 | 0.070 |
Why?
|
| Maternal Age | 2 | 2003 | 809 | 0.070 |
Why?
|
| Hemodynamics | 7 | 2005 | 4160 | 0.070 |
Why?
|
| Perception | 3 | 2015 | 1197 | 0.070 |
Why?
|
| Denmark | 2 | 2020 | 771 | 0.070 |
Why?
|
| Convalescence | 1 | 2007 | 105 | 0.070 |
Why?
|
| Tobacco Use Cessation | 1 | 2008 | 94 | 0.070 |
Why?
|
| Markov Chains | 2 | 2009 | 966 | 0.070 |
Why?
|
| Pain, Intractable | 1 | 2008 | 132 | 0.070 |
Why?
|
| Veterans Disability Claims | 1 | 2006 | 24 | 0.070 |
Why?
|
| Pericardium | 1 | 1991 | 675 | 0.070 |
Why?
|
| Health Care Rationing | 1 | 2010 | 437 | 0.070 |
Why?
|
| Secondary Prevention | 1 | 2013 | 1475 | 0.070 |
Why?
|
| Circadian Rhythm | 4 | 2021 | 2576 | 0.070 |
Why?
|
| Georgia | 1 | 2007 | 185 | 0.070 |
Why?
|
| Lung Diseases, Fungal | 2 | 1998 | 126 | 0.070 |
Why?
|
| Graft Rejection | 3 | 2017 | 4446 | 0.070 |
Why?
|
| Urban Health | 1 | 2009 | 532 | 0.070 |
Why?
|
| South America | 2 | 2016 | 179 | 0.070 |
Why?
|
| Jugular Veins | 1 | 2008 | 210 | 0.070 |
Why?
|
| Stereotyping | 1 | 2008 | 239 | 0.070 |
Why?
|
| Public Sector | 1 | 2008 | 267 | 0.070 |
Why?
|
| Infant, Newborn | 7 | 2023 | 26198 | 0.070 |
Why?
|
| Qualitative Research | 2 | 2020 | 3023 | 0.070 |
Why?
|
| Neuropsychological Tests | 3 | 2016 | 7054 | 0.070 |
Why?
|
| Case Management | 1 | 2008 | 272 | 0.070 |
Why?
|
| Sudden Infant Death | 2 | 2000 | 292 | 0.070 |
Why?
|
| Hospitals, University | 2 | 2020 | 564 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 1996 | 2645 | 0.070 |
Why?
|
| Carrier Proteins | 2 | 2016 | 4937 | 0.070 |
Why?
|
| Individuality | 2 | 2006 | 301 | 0.070 |
Why?
|
| Language | 1 | 2015 | 1540 | 0.060 |
Why?
|
| Blood Flow Velocity | 1 | 2010 | 1371 | 0.060 |
Why?
|
| Peru | 2 | 2019 | 891 | 0.060 |
Why?
|
| Graft Survival | 4 | 2024 | 3820 | 0.060 |
Why?
|
| Attitude of Health Personnel | 3 | 2015 | 3889 | 0.060 |
Why?
|
| Mass Media | 1 | 1988 | 303 | 0.060 |
Why?
|
| Burns | 1 | 2017 | 1882 | 0.060 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2006 | 1722 | 0.060 |
Why?
|
| Interdisciplinary Communication | 2 | 2013 | 931 | 0.060 |
Why?
|
| Likelihood Functions | 2 | 2000 | 992 | 0.060 |
Why?
|
| Ketones | 1 | 2006 | 184 | 0.060 |
Why?
|
| Hematologic Diseases | 2 | 2006 | 496 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2013 | 1881 | 0.060 |
Why?
|
| Respiratory Tract Infections | 1 | 2013 | 1010 | 0.060 |
Why?
|
| Evaluation Studies as Topic | 3 | 1998 | 1624 | 0.060 |
Why?
|
| Fever | 2 | 2009 | 1618 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 3701 | 0.060 |
Why?
|
| Immunoglobulin E | 1 | 2011 | 1502 | 0.060 |
Why?
|
| Nutritional Status | 1 | 2013 | 1615 | 0.060 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2010 | 740 | 0.060 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 4853 | 0.060 |
Why?
|
| Survival Rate | 8 | 2024 | 12725 | 0.060 |
Why?
|
| Testicular Hydrocele | 1 | 1984 | 27 | 0.060 |
Why?
|
| Quadruplets | 1 | 1984 | 9 | 0.060 |
Why?
|
| Psychological Tests | 3 | 2006 | 640 | 0.060 |
Why?
|
| Private Sector | 1 | 2008 | 398 | 0.060 |
Why?
|
| Carcinoma | 1 | 2016 | 2330 | 0.060 |
Why?
|
| Amitriptyline | 1 | 2005 | 112 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2017 | 3677 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10766 | 0.060 |
Why?
|
| Cisplatin | 2 | 2005 | 1652 | 0.060 |
Why?
|
| Bronchi | 3 | 2017 | 845 | 0.060 |
Why?
|
| Myocardial Contraction | 1 | 2010 | 1515 | 0.060 |
Why?
|
| Health Priorities | 1 | 2007 | 374 | 0.060 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2006 | 257 | 0.060 |
Why?
|
| Phrenic Nerve | 1 | 2004 | 79 | 0.060 |
Why?
|
| National Health Programs | 2 | 2000 | 440 | 0.060 |
Why?
|
| Varicocele | 1 | 1984 | 75 | 0.060 |
Why?
|
| Emergencies | 1 | 1991 | 1217 | 0.060 |
Why?
|
| Internal Medicine | 2 | 2005 | 1051 | 0.060 |
Why?
|
| Dyspnea | 2 | 2010 | 1347 | 0.060 |
Why?
|
| Glucocorticoids | 1 | 2013 | 2161 | 0.060 |
Why?
|
| Health Care Reform | 2 | 2007 | 1247 | 0.060 |
Why?
|
| Speech | 2 | 2000 | 554 | 0.060 |
Why?
|
| Child Welfare | 1 | 2008 | 521 | 0.060 |
Why?
|
| Canada | 2 | 2007 | 2122 | 0.060 |
Why?
|
| Bacteria | 1 | 1995 | 2199 | 0.060 |
Why?
|
| Twins | 3 | 1994 | 339 | 0.060 |
Why?
|
| Climate Change | 1 | 2010 | 501 | 0.060 |
Why?
|
| Hospital Costs | 2 | 2006 | 947 | 0.050 |
Why?
|
| Social Perception | 2 | 1993 | 433 | 0.050 |
Why?
|
| Vinblastine | 1 | 2005 | 488 | 0.050 |
Why?
|
| Allelic Imbalance | 1 | 2003 | 77 | 0.050 |
Why?
|
| Aerospace Medicine | 1 | 2004 | 95 | 0.050 |
Why?
|
| Patient Care Management | 1 | 2006 | 302 | 0.050 |
Why?
|
| Digestive System Diseases | 1 | 2005 | 151 | 0.050 |
Why?
|
| Private Practice | 2 | 1999 | 153 | 0.050 |
Why?
|
| Neoplasms | 5 | 2020 | 22172 | 0.050 |
Why?
|
| Neurobiology | 1 | 2024 | 137 | 0.050 |
Why?
|
| Somatosensory Cortex | 1 | 1987 | 512 | 0.050 |
Why?
|
| Mortality | 1 | 2014 | 2901 | 0.050 |
Why?
|
| Dilatation | 2 | 2005 | 306 | 0.050 |
Why?
|
| Abdominal Pain | 1 | 2009 | 1071 | 0.050 |
Why?
|
| Biological Availability | 1 | 2023 | 390 | 0.050 |
Why?
|
| Beds | 1 | 2003 | 47 | 0.050 |
Why?
|
| Prefrontal Cortex | 2 | 2024 | 2220 | 0.050 |
Why?
|
| Ethics, Medical | 1 | 1988 | 783 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2018 | 3429 | 0.050 |
Why?
|
| Lung | 6 | 2017 | 10002 | 0.050 |
Why?
|
| Critical Illness | 1 | 2015 | 2723 | 0.050 |
Why?
|
| Amyloidosis | 1 | 2009 | 817 | 0.050 |
Why?
|
| Parkinson Disease | 1 | 2016 | 2877 | 0.050 |
Why?
|
| Phytotherapy | 2 | 2002 | 296 | 0.050 |
Why?
|
| Risk Reduction Behavior | 1 | 2008 | 1112 | 0.050 |
Why?
|
| Military Psychiatry | 1 | 2021 | 22 | 0.050 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2005 | 370 | 0.050 |
Why?
|
| Health Benefit Plans, Employee | 2 | 2007 | 333 | 0.050 |
Why?
|
| Frontal Lobe | 4 | 2020 | 1420 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2008 | 2048 | 0.050 |
Why?
|
| Attention | 3 | 2010 | 2396 | 0.050 |
Why?
|
| Deoxyglucose | 8 | 1989 | 333 | 0.050 |
Why?
|
| Hypercholesterolemia | 1 | 2008 | 1141 | 0.050 |
Why?
|
| Psychology | 3 | 2009 | 356 | 0.050 |
Why?
|
| Psychophysiology | 1 | 2021 | 136 | 0.050 |
Why?
|
| Biopsy | 3 | 2017 | 6766 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2017 | 20569 | 0.050 |
Why?
|
| Defense Mechanisms | 3 | 1999 | 180 | 0.050 |
Why?
|
| North America | 2 | 1998 | 1276 | 0.050 |
Why?
|
| Testis | 1 | 1984 | 794 | 0.050 |
Why?
|
| Prone Position | 2 | 2000 | 196 | 0.050 |
Why?
|
| Self Disclosure | 3 | 2010 | 249 | 0.050 |
Why?
|
| Voluntary Health Agencies | 1 | 2000 | 38 | 0.050 |
Why?
|
| Diagnostic Errors | 1 | 2008 | 1265 | 0.050 |
Why?
|
| Least-Squares Analysis | 1 | 2001 | 369 | 0.040 |
Why?
|
| Hippocampus | 3 | 2024 | 3766 | 0.040 |
Why?
|
| Deoxycytidine | 1 | 2005 | 877 | 0.040 |
Why?
|
| Mutation | 3 | 2017 | 30054 | 0.040 |
Why?
|
| Gyrus Cinguli | 2 | 2023 | 1115 | 0.040 |
Why?
|
| Mothers | 2 | 1994 | 2198 | 0.040 |
Why?
|
| Male Urogenital Diseases | 1 | 2020 | 48 | 0.040 |
Why?
|
| Kynurenine | 1 | 2020 | 141 | 0.040 |
Why?
|
| Osteoporosis | 1 | 2010 | 1606 | 0.040 |
Why?
|
| Blood Loss, Surgical | 3 | 1998 | 638 | 0.040 |
Why?
|
| Public Assistance | 1 | 2000 | 47 | 0.040 |
Why?
|
| Female Urogenital Diseases | 1 | 2020 | 57 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2014 | 2578 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 1667 | 0.040 |
Why?
|
| Database Management Systems | 1 | 2021 | 257 | 0.040 |
Why?
|
| Waiting Lists | 1 | 2024 | 765 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2011 | 12341 | 0.040 |
Why?
|
| Imitative Behavior | 2 | 1989 | 35 | 0.040 |
Why?
|
| Anisotropy | 1 | 2023 | 1283 | 0.040 |
Why?
|
| Carbon Dioxide | 4 | 2001 | 1147 | 0.040 |
Why?
|
| Medical History Taking | 2 | 2021 | 774 | 0.040 |
Why?
|
| Physical Fitness | 1 | 2004 | 743 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 10194 | 0.040 |
Why?
|
| Carcinoma, Bronchogenic | 2 | 1996 | 87 | 0.040 |
Why?
|
| Northern Ireland | 1 | 2018 | 37 | 0.040 |
Why?
|
| Afferent Pathways | 1 | 2000 | 298 | 0.040 |
Why?
|
| Genetics, Behavioral | 1 | 2019 | 53 | 0.040 |
Why?
|
| Carcinoma, Small Cell | 1 | 2001 | 420 | 0.040 |
Why?
|
| Portugal | 1 | 2018 | 91 | 0.040 |
Why?
|
| Medical Records | 1 | 2004 | 1408 | 0.040 |
Why?
|
| Romania | 1 | 2018 | 92 | 0.040 |
Why?
|
| Hypothalamus | 1 | 2024 | 999 | 0.040 |
Why?
|
| Utilization Review | 2 | 2011 | 382 | 0.040 |
Why?
|
| Mother-Child Relations | 1 | 2003 | 495 | 0.040 |
Why?
|
| Medically Uninsured | 2 | 2002 | 836 | 0.040 |
Why?
|
| Ascites | 1 | 2020 | 338 | 0.040 |
Why?
|
| Sjogren's Syndrome | 1 | 2020 | 238 | 0.040 |
Why?
|
| Arousal | 3 | 2022 | 1166 | 0.040 |
Why?
|
| Acute Disease | 2 | 2008 | 7237 | 0.040 |
Why?
|
| Hantavirus Pulmonary Syndrome | 1 | 1998 | 11 | 0.040 |
Why?
|
| Anorexia Nervosa | 2 | 2006 | 1361 | 0.040 |
Why?
|
| Actuarial Analysis | 2 | 1995 | 372 | 0.040 |
Why?
|
| Extinction, Psychological | 1 | 2021 | 371 | 0.040 |
Why?
|
| Organizational Culture | 1 | 2022 | 508 | 0.040 |
Why?
|
| Seasonal Affective Disorder | 1 | 1998 | 49 | 0.040 |
Why?
|
| Cerebral Cortex | 4 | 2024 | 5779 | 0.040 |
Why?
|
| Thinking | 1 | 2001 | 320 | 0.040 |
Why?
|
| Disease Management | 1 | 2008 | 2508 | 0.040 |
Why?
|
| Fluorodeoxyglucose F18 | 6 | 2018 | 2010 | 0.040 |
Why?
|
| Disease Outbreaks | 2 | 2021 | 1749 | 0.040 |
Why?
|
| Spirometry | 2 | 2005 | 929 | 0.040 |
Why?
|
| Paternal Age | 1 | 1997 | 87 | 0.040 |
Why?
|
| Periosteum | 1 | 1998 | 139 | 0.040 |
Why?
|
| Self-Help Groups | 1 | 1999 | 192 | 0.040 |
Why?
|
| General Practitioners | 1 | 2018 | 101 | 0.040 |
Why?
|
| Social Justice | 1 | 2022 | 478 | 0.040 |
Why?
|
| State Health Plans | 1 | 1999 | 219 | 0.040 |
Why?
|
| Bronchial Diseases | 1 | 1998 | 150 | 0.040 |
Why?
|
| Professional Practice | 1 | 1999 | 313 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 2 | 1995 | 1936 | 0.030 |
Why?
|
| Feces | 1 | 2023 | 1497 | 0.030 |
Why?
|
| AIDS Serodiagnosis | 2 | 1989 | 220 | 0.030 |
Why?
|
| Pressure | 1 | 2000 | 1154 | 0.030 |
Why?
|
| Cardiovascular System | 1 | 2004 | 834 | 0.030 |
Why?
|
| Job Satisfaction | 1 | 2001 | 544 | 0.030 |
Why?
|
| 1-Deoxynojirimycin | 1 | 2016 | 18 | 0.030 |
Why?
|
| Arteries | 2 | 1999 | 1123 | 0.030 |
Why?
|
| Mitotic Index | 1 | 1996 | 162 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 2 | 2019 | 1702 | 0.030 |
Why?
|
| Bone Density | 1 | 2010 | 3551 | 0.030 |
Why?
|
| Test Anxiety Scale | 1 | 2016 | 4 | 0.030 |
Why?
|
| Psychology, Educational | 1 | 2016 | 6 | 0.030 |
Why?
|
| Ethanol | 1 | 2023 | 1324 | 0.030 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 426 | 0.030 |
Why?
|
| Alcohol Amnestic Disorder | 1 | 1996 | 35 | 0.030 |
Why?
|
| Technology Assessment, Biomedical | 1 | 1999 | 307 | 0.030 |
Why?
|
| Personality Tests | 3 | 1991 | 81 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 2016 | 397 | 0.030 |
Why?
|
| Immune System | 1 | 2022 | 796 | 0.030 |
Why?
|
| Quality Assurance, Health Care | 1 | 2006 | 2169 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2018 | 224 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2013 | 4021 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2004 | 3597 | 0.030 |
Why?
|
| Empyema, Tuberculous | 1 | 1995 | 2 | 0.030 |
Why?
|
| Pneumothorax, Artificial | 1 | 1995 | 5 | 0.030 |
Why?
|
| Aspergillosis | 1 | 1998 | 242 | 0.030 |
Why?
|
| Cerebral Decortication | 1 | 1995 | 11 | 0.030 |
Why?
|
| Fatigue | 1 | 2023 | 1552 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2000 | 4016 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2006 | 2759 | 0.030 |
Why?
|
| Wernicke Encephalopathy | 1 | 1996 | 29 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 1998 | 472 | 0.030 |
Why?
|
| Quality Control | 1 | 1999 | 832 | 0.030 |
Why?
|
| Tissue and Organ Procurement | 1 | 2024 | 962 | 0.030 |
Why?
|
| Transients and Migrants | 1 | 2018 | 165 | 0.030 |
Why?
|
| Tuberculosis, Pulmonary | 3 | 1998 | 832 | 0.030 |
Why?
|
| Adoption | 2 | 1993 | 97 | 0.030 |
Why?
|
| Contraception Behavior | 1 | 1997 | 182 | 0.030 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2020 | 575 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2021 | 727 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2024 | 4615 | 0.030 |
Why?
|
| Genetic Variation | 2 | 2023 | 6567 | 0.030 |
Why?
|
| Memory | 2 | 2008 | 2193 | 0.030 |
Why?
|
| Appetite Depressants | 1 | 1996 | 108 | 0.030 |
Why?
|
| Standard of Care | 1 | 2019 | 551 | 0.030 |
Why?
|
| Adolescent Psychiatry | 1 | 1997 | 157 | 0.030 |
Why?
|
| Sickness Impact Profile | 2 | 2007 | 299 | 0.030 |
Why?
|
| Stroke | 2 | 2015 | 9758 | 0.030 |
Why?
|
| Coronary Disease | 1 | 2010 | 5914 | 0.030 |
Why?
|
| Fatal Outcome | 2 | 2016 | 1835 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2016 | 350 | 0.030 |
Why?
|
| Small-Area Analysis | 1 | 2015 | 55 | 0.030 |
Why?
|
| Bone Regeneration | 1 | 1998 | 432 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 8601 | 0.030 |
Why?
|
| Device Removal | 1 | 2020 | 630 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2016 | 386 | 0.030 |
Why?
|
| Diaphragm | 1 | 2016 | 351 | 0.030 |
Why?
|
| Blood Transfusion, Autologous | 2 | 1992 | 130 | 0.030 |
Why?
|
| Homozygote | 1 | 2019 | 1776 | 0.030 |
Why?
|
| Cocaine | 2 | 1997 | 958 | 0.030 |
Why?
|
| Contrast Media | 1 | 2008 | 5307 | 0.030 |
Why?
|
| Accident Prevention | 1 | 2014 | 76 | 0.030 |
Why?
|
| Genome | 1 | 2022 | 1740 | 0.030 |
Why?
|
| Taxoids | 2 | 2010 | 668 | 0.030 |
Why?
|
| Drug Industry | 1 | 2001 | 788 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2021 | 1336 | 0.030 |
Why?
|
| Diagnostic Techniques, Respiratory System | 1 | 2013 | 12 | 0.030 |
Why?
|
| Child Psychiatry | 1 | 1997 | 228 | 0.030 |
Why?
|
| Clinical Trials as Topic | 3 | 2024 | 8002 | 0.030 |
Why?
|
| Hospitals | 2 | 2021 | 3882 | 0.030 |
Why?
|
| Chicago | 5 | 1998 | 254 | 0.030 |
Why?
|
| Random Allocation | 4 | 2001 | 2395 | 0.030 |
Why?
|
| Genomics | 2 | 2020 | 5821 | 0.030 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2013 | 94 | 0.030 |
Why?
|
| Macrolides | 1 | 1995 | 205 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 11461 | 0.030 |
Why?
|
| Insurance Claim Review | 2 | 2009 | 741 | 0.030 |
Why?
|
| Vesicular Transport Proteins | 1 | 2016 | 376 | 0.030 |
Why?
|
| Skull | 1 | 1998 | 818 | 0.030 |
Why?
|
| Neoplasm Staging | 4 | 2010 | 11120 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2010 | 4878 | 0.030 |
Why?
|
| United States Government Agencies | 1 | 2012 | 26 | 0.030 |
Why?
|
| Remission Induction | 1 | 2019 | 2397 | 0.030 |
Why?
|
| Hyperthermia, Induced | 1 | 2016 | 417 | 0.030 |
Why?
|
| Cattle Diseases | 1 | 1992 | 51 | 0.030 |
Why?
|
| Sleep Stages | 2 | 2010 | 694 | 0.030 |
Why?
|
| Computer-Assisted Instruction | 1 | 2015 | 362 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2020 | 1616 | 0.030 |
Why?
|
| Autonomic Nervous System | 1 | 2017 | 703 | 0.030 |
Why?
|
| Anaplasmosis | 1 | 1992 | 37 | 0.030 |
Why?
|
| Acetylcysteine | 1 | 2013 | 260 | 0.030 |
Why?
|
| Necrosis | 1 | 1996 | 1611 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2018 | 1567 | 0.020 |
Why?
|
| Cathartics | 1 | 1993 | 127 | 0.020 |
Why?
|
| Blood | 1 | 1994 | 596 | 0.020 |
Why?
|
| Tracheostomy | 1 | 1996 | 426 | 0.020 |
Why?
|
| Exercise | 1 | 2008 | 5890 | 0.020 |
Why?
|
| Anticoagulants | 2 | 2020 | 4812 | 0.020 |
Why?
|
| Nicotine | 1 | 1997 | 680 | 0.020 |
Why?
|
| Lung Volume Measurements | 1 | 1992 | 375 | 0.020 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1996 | 710 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2020 | 3779 | 0.020 |
Why?
|
| Patient-Centered Care | 1 | 2001 | 1421 | 0.020 |
Why?
|
| Longevity | 1 | 2019 | 1065 | 0.020 |
Why?
|
| Candidiasis, Oral | 1 | 1991 | 57 | 0.020 |
Why?
|
| Babesiosis | 1 | 1992 | 92 | 0.020 |
Why?
|
| Hernia | 1 | 1991 | 68 | 0.020 |
Why?
|
| Nerve Net | 1 | 2023 | 2291 | 0.020 |
Why?
|
| Premenstrual Syndrome | 1 | 1992 | 109 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 2898 | 0.020 |
Why?
|
| Vasectomy | 1 | 1991 | 51 | 0.020 |
Why?
|
| Medicare | 2 | 2006 | 6770 | 0.020 |
Why?
|
| Endometrial Neoplasms | 1 | 2000 | 1366 | 0.020 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1995 | 646 | 0.020 |
Why?
|
| Iran | 1 | 2014 | 737 | 0.020 |
Why?
|
| Transplantation, Homologous | 2 | 2010 | 4807 | 0.020 |
Why?
|
| Schizophrenic Psychology | 3 | 1989 | 1647 | 0.020 |
Why?
|
| Penile Erection | 1 | 1991 | 100 | 0.020 |
Why?
|
| Health Education | 2 | 2015 | 1052 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2022 | 3113 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2013 | 1178 | 0.020 |
Why?
|
| Sperm Count | 1 | 1991 | 229 | 0.020 |
Why?
|
| Drug Costs | 3 | 2007 | 1183 | 0.020 |
Why?
|
| Fluorine | 3 | 1985 | 83 | 0.020 |
Why?
|
| Decision Support Techniques | 2 | 2011 | 1998 | 0.020 |
Why?
|
| Family Characteristics | 2 | 1999 | 1004 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2018 | 2767 | 0.020 |
Why?
|
| Epothilones | 1 | 2010 | 42 | 0.020 |
Why?
|
| Cyclothymic Disorder | 1 | 2010 | 42 | 0.020 |
Why?
|
| Sperm Motility | 1 | 1991 | 266 | 0.020 |
Why?
|
| Trachea | 1 | 1996 | 1089 | 0.020 |
Why?
|
| Heroin Dependence | 1 | 1991 | 172 | 0.020 |
Why?
|
| Solubility | 1 | 1992 | 1091 | 0.020 |
Why?
|
| Ciprofloxacin | 1 | 1992 | 312 | 0.020 |
Why?
|
| Clinical Competence | 3 | 2015 | 4793 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2000 | 2220 | 0.020 |
Why?
|
| Fluorouracil | 1 | 1995 | 1642 | 0.020 |
Why?
|
| Haiti | 1 | 2011 | 550 | 0.020 |
Why?
|
| Thoracotomy | 2 | 2004 | 367 | 0.020 |
Why?
|
| Accidents | 1 | 2010 | 165 | 0.020 |
Why?
|
| Postoperative Period | 2 | 1991 | 1814 | 0.020 |
Why?
|
| Respiration | 1 | 1996 | 1657 | 0.020 |
Why?
|
| Rescue Work | 1 | 2009 | 56 | 0.020 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 1970 | 139 | 0.020 |
Why?
|
| Heart Failure | 3 | 2020 | 11671 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 1964 | 0.020 |
Why?
|
| Economics | 1 | 1989 | 141 | 0.020 |
Why?
|
| Skin | 1 | 1983 | 4484 | 0.020 |
Why?
|
| Diet, Reducing | 2 | 1991 | 485 | 0.020 |
Why?
|
| Dominance, Cerebral | 3 | 1989 | 623 | 0.020 |
Why?
|
| Radioisotopes | 3 | 1985 | 499 | 0.020 |
Why?
|
| Africa South of the Sahara | 1 | 2011 | 744 | 0.020 |
Why?
|
| Absorptiometry, Photon | 2 | 2010 | 1738 | 0.020 |
Why?
|
| Chiropractic | 2 | 2003 | 39 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2018 | 2651 | 0.020 |
Why?
|
| Massage | 2 | 2003 | 86 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2000 | 2538 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2010 | 21019 | 0.020 |
Why?
|
| Cultural Competency | 1 | 2011 | 300 | 0.020 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2010 | 352 | 0.020 |
Why?
|
| C-Peptide | 1 | 2010 | 440 | 0.020 |
Why?
|
| Quinolones | 1 | 1992 | 378 | 0.020 |
Why?
|
| Child, Orphaned | 1 | 2008 | 55 | 0.020 |
Why?
|
| Allostasis | 1 | 2009 | 72 | 0.020 |
Why?
|
| Parenting | 1 | 1994 | 701 | 0.020 |
Why?
|
| Alleles | 1 | 2019 | 6864 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2020 | 3060 | 0.020 |
Why?
|
| Intubation, Intratracheal | 1 | 1996 | 1333 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2000 | 2223 | 0.020 |
Why?
|
| Intraoperative Complications | 2 | 1995 | 1166 | 0.020 |
Why?
|
| Antibodies | 2 | 2013 | 2418 | 0.020 |
Why?
|
| Critical Pathways | 1 | 2011 | 474 | 0.020 |
Why?
|
| Religion and Psychology | 1 | 1990 | 180 | 0.020 |
Why?
|
| Cerebral Ventricles | 3 | 1986 | 542 | 0.020 |
Why?
|
| Cardiomegaly | 1 | 2010 | 590 | 0.020 |
Why?
|
| Prosthesis Design | 2 | 1994 | 2115 | 0.020 |
Why?
|
| Leg | 1 | 1993 | 1088 | 0.020 |
Why?
|
| Prostheses and Implants | 2 | 1998 | 1271 | 0.020 |
Why?
|
| Maximum Tolerated Dose | 1 | 2010 | 883 | 0.020 |
Why?
|
| Relaxation Therapy | 2 | 2003 | 181 | 0.020 |
Why?
|
| Mentally Ill Persons | 1 | 1988 | 128 | 0.020 |
Why?
|
| Angiography | 1 | 1993 | 1595 | 0.020 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2010 | 324 | 0.020 |
Why?
|
| Pregnancy | 4 | 2011 | 29876 | 0.020 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2010 | 450 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1991 | 1596 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2020 | 3744 | 0.020 |
Why?
|
| Aggression | 1 | 2012 | 750 | 0.020 |
Why?
|
| Choice Behavior | 2 | 2005 | 824 | 0.020 |
Why?
|
| Medical Errors | 1 | 2015 | 1263 | 0.020 |
Why?
|
| Urethra | 1 | 1989 | 405 | 0.020 |
Why?
|
| Scotland | 1 | 2006 | 143 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2020 | 5293 | 0.020 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 1998 | 1462 | 0.020 |
Why?
|
| Hemorrhoids | 1 | 1986 | 19 | 0.020 |
Why?
|
| Cognition Disorders | 2 | 2010 | 3980 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 3808 | 0.020 |
Why?
|
| Collagen | 2 | 1998 | 2638 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 2 | 1992 | 3627 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 2872 | 0.020 |
Why?
|
| Atrophy | 2 | 1996 | 1633 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2010 | 1494 | 0.020 |
Why?
|
| Barbiturates | 2 | 1976 | 113 | 0.020 |
Why?
|
| Air Pollution, Indoor | 1 | 2013 | 901 | 0.020 |
Why?
|
| Anti-Anxiety Agents | 1 | 2008 | 397 | 0.020 |
Why?
|
| Glucose | 4 | 1985 | 4347 | 0.020 |
Why?
|
| Amphetamines | 2 | 1976 | 143 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 1992 | 1301 | 0.020 |
Why?
|
| Research Personnel | 1 | 2010 | 588 | 0.020 |
Why?
|
| Policy Making | 2 | 2001 | 542 | 0.020 |
Why?
|
| Wales | 1 | 2005 | 87 | 0.020 |
Why?
|
| Decision Making | 1 | 1999 | 3929 | 0.020 |
Why?
|
| Pleural Diseases | 2 | 1996 | 137 | 0.020 |
Why?
|
| Child Development | 1 | 1997 | 2306 | 0.020 |
Why?
|
| Mathematical Computing | 1 | 2005 | 142 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 1996 | 2630 | 0.010 |
Why?
|
| Rectal Diseases | 1 | 1986 | 143 | 0.010 |
Why?
|
| Truth Disclosure | 1 | 1989 | 434 | 0.010 |
Why?
|
| Urinary Incontinence | 1 | 1989 | 489 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 2850 | 0.010 |
Why?
|
| Varicose Veins | 1 | 1986 | 155 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 2010 | 1189 | 0.010 |
Why?
|
| Observer Variation | 2 | 2006 | 2606 | 0.010 |
Why?
|
| Temporal Lobe | 2 | 1989 | 1695 | 0.010 |
Why?
|
| Ligation | 1 | 1984 | 448 | 0.010 |
Why?
|
| Hypertension, Portal | 1 | 1986 | 226 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 1999 | 9281 | 0.010 |
Why?
|
| Physical Stimulation | 1 | 2005 | 517 | 0.010 |
Why?
|
| Brain Injuries | 1 | 2015 | 2054 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1992 | 1391 | 0.010 |
Why?
|
| England | 1 | 2005 | 526 | 0.010 |
Why?
|
| Wakefulness | 1 | 2010 | 1265 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2010 | 1315 | 0.010 |
Why?
|
| Politics | 1 | 2010 | 815 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2010 | 2224 | 0.010 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2003 | 191 | 0.010 |
Why?
|
| Life Expectancy | 1 | 1990 | 1242 | 0.010 |
Why?
|
| Weight Gain | 1 | 1993 | 2348 | 0.010 |
Why?
|
| Software | 1 | 1997 | 4434 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 1991 | 2188 | 0.010 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2003 | 271 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 2010 | 1161 | 0.010 |
Why?
|
| Systole | 1 | 2004 | 936 | 0.010 |
Why?
|
| Evoked Potentials, Visual | 1 | 1984 | 417 | 0.010 |
Why?
|
| Cytokines | 1 | 2017 | 7396 | 0.010 |
Why?
|
| Echocardiography, Doppler | 1 | 2005 | 897 | 0.010 |
Why?
|
| Body Weight | 2 | 1991 | 4618 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 1989 | 1505 | 0.010 |
Why?
|
| Informed Consent | 1 | 1988 | 1008 | 0.010 |
Why?
|
| Life Style | 4 | 2004 | 3917 | 0.010 |
Why?
|
| History, Modern 1601- | 1 | 1981 | 16 | 0.010 |
Why?
|
| Hemodilution | 2 | 1992 | 120 | 0.010 |
Why?
|
| Vaccination | 1 | 2013 | 3384 | 0.010 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1984 | 530 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2000 | 5821 | 0.010 |
Why?
|
| Hyperalgesia | 1 | 2005 | 532 | 0.010 |
Why?
|
| Tourette Syndrome | 1 | 1984 | 395 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2010 | 2244 | 0.010 |
Why?
|
| Endoscopy | 1 | 2010 | 1851 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2013 | 3537 | 0.010 |
Why?
|
| Exercise Tolerance | 1 | 2005 | 836 | 0.010 |
Why?
|
| Veins | 1 | 1984 | 768 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 2001 | 206 | 0.010 |
Why?
|
| Receptors, Serotonin | 1 | 2001 | 208 | 0.010 |
Why?
|
| Etoposide | 1 | 2001 | 634 | 0.010 |
Why?
|
| New York | 3 | 1977 | 874 | 0.010 |
Why?
|
| Cost Allocation | 1 | 1999 | 49 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 3530 | 0.010 |
Why?
|
| Direct Service Costs | 1 | 1999 | 59 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2003 | 571 | 0.010 |
Why?
|
| Preoperative Care | 3 | 1995 | 2242 | 0.010 |
Why?
|
| Maximal Voluntary Ventilation | 1 | 1998 | 14 | 0.010 |
Why?
|
| Insulin | 1 | 2013 | 6597 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2005 | 2079 | 0.010 |
Why?
|
| Nociceptors | 1 | 1983 | 461 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 2118 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1986 | 1116 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1991 | 4369 | 0.010 |
Why?
|
| Electroencephalography | 2 | 1984 | 6237 | 0.010 |
Why?
|
| Implosive Therapy | 1 | 2000 | 125 | 0.010 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 1998 | 41 | 0.010 |
Why?
|
| Life Tables | 1 | 1998 | 364 | 0.010 |
Why?
|
| Carboplatin | 1 | 2001 | 794 | 0.010 |
Why?
|
| Animals | 5 | 1999 | 168475 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2010 | 4471 | 0.010 |
Why?
|
| Exercise Test | 1 | 2005 | 2127 | 0.010 |
Why?
|
| Thoracostomy | 1 | 1998 | 74 | 0.010 |
Why?
|
| Fibroblast Growth Factors | 1 | 2003 | 867 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1983 | 1736 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 1998 | 311 | 0.010 |
Why?
|
| Point-of-Care Systems | 1 | 2006 | 1213 | 0.010 |
Why?
|
| Antimetabolites | 1 | 1998 | 129 | 0.010 |
Why?
|
| Intraoperative Care | 2 | 1992 | 767 | 0.010 |
Why?
|
| Osteocalcin | 1 | 1998 | 274 | 0.010 |
Why?
|
| Adenocarcinoma | 2 | 2010 | 6346 | 0.010 |
Why?
|
| Opium | 1 | 1976 | 27 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2010 | 3964 | 0.010 |
Why?
|
| Condoms | 1 | 1998 | 331 | 0.010 |
Why?
|
| Pleura | 1 | 1998 | 245 | 0.010 |
Why?
|
| Polyglycolic Acid | 1 | 1998 | 406 | 0.010 |
Why?
|
| Calcitriol | 1 | 1998 | 296 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2011 | 3801 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2010 | 6377 | 0.010 |
Why?
|
| Empyema, Pleural | 1 | 1996 | 61 | 0.010 |
Why?
|
| Osteocytes | 1 | 1998 | 192 | 0.010 |
Why?
|
| Bronchial Fistula | 1 | 1996 | 83 | 0.010 |
Why?
|
| Lysergic Acid Diethylamide | 1 | 1976 | 47 | 0.010 |
Why?
|
| Diastole | 1 | 1998 | 782 | 0.010 |
Why?
|
| Thoracoplasty | 1 | 1995 | 15 | 0.010 |
Why?
|
| Cardiac Output | 1 | 1998 | 831 | 0.010 |
Why?
|
| Biotechnology | 1 | 1998 | 282 | 0.010 |
Why?
|
| Psychology, Social | 1 | 1995 | 52 | 0.010 |
Why?
|
| Connective Tissue | 1 | 1998 | 419 | 0.010 |
Why?
|
| Physical Exertion | 1 | 1998 | 667 | 0.010 |
Why?
|
| Diagnosis-Related Groups | 1 | 1997 | 449 | 0.010 |
Why?
|
| Heroin | 1 | 1976 | 119 | 0.010 |
Why?
|
| Surgical Mesh | 1 | 1998 | 311 | 0.010 |
Why?
|
| Culture | 1 | 1979 | 623 | 0.010 |
Why?
|
| Blood-Borne Pathogens | 1 | 1994 | 52 | 0.010 |
Why?
|
| Fistula | 1 | 1996 | 212 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2010 | 3407 | 0.010 |
Why?
|
| Postoperative Hemorrhage | 1 | 1998 | 415 | 0.010 |
Why?
|
| Social Behavior | 1 | 2001 | 1135 | 0.010 |
Why?
|
| Caudate Nucleus | 2 | 1986 | 390 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 12149 | 0.010 |
Why?
|
| Motor Activity | 1 | 2004 | 2715 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 1989 | 4235 | 0.010 |
Why?
|
| Rest | 1 | 1998 | 918 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1998 | 2468 | 0.010 |
Why?
|
| Jurisprudence | 1 | 1993 | 109 | 0.010 |
Why?
|
| Pulmonary Emphysema | 1 | 1998 | 684 | 0.010 |
Why?
|
| Anaplasma | 1 | 1992 | 5 | 0.010 |
Why?
|
| West Indies | 1 | 1992 | 32 | 0.010 |
Why?
|
| Arachnid Vectors | 1 | 1992 | 24 | 0.010 |
Why?
|
| Constriction | 1 | 1993 | 168 | 0.010 |
Why?
|
| Episode of Care | 1 | 1993 | 128 | 0.010 |
Why?
|
| HIV Infections | 2 | 2010 | 17352 | 0.010 |
Why?
|
| Iatrogenic Disease | 1 | 1996 | 540 | 0.010 |
Why?
|
| Chondrocytes | 1 | 1998 | 795 | 0.010 |
Why?
|
| Babesia | 1 | 1992 | 29 | 0.010 |
Why?
|
| Neurotic Disorders | 1 | 1992 | 77 | 0.010 |
Why?
|
| Bloodletting | 1 | 1992 | 22 | 0.010 |
Why?
|
| Osteoblasts | 1 | 1998 | 1143 | 0.010 |
Why?
|
| United States Food and Drug Administration | 1 | 2001 | 1664 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 1995 | 13642 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 1998 | 1386 | 0.010 |
Why?
|
| Insect Vectors | 1 | 1992 | 136 | 0.010 |
Why?
|
| Drug Utilization | 1 | 1998 | 1188 | 0.010 |
Why?
|
| Rabbits | 1 | 1998 | 4772 | 0.010 |
Why?
|
| Hyperemia | 1 | 1993 | 221 | 0.010 |
Why?
|
| Pediatrics | 1 | 1986 | 3589 | 0.010 |
Why?
|
| Temperament | 1 | 1993 | 297 | 0.010 |
Why?
|
| Home Care Services | 1 | 1997 | 648 | 0.010 |
Why?
|
| Hematocrit | 1 | 1992 | 623 | 0.010 |
Why?
|
| Germany, West | 1 | 1970 | 13 | 0.010 |
Why?
|
| Complement Fixation Tests | 1 | 1970 | 68 | 0.010 |
Why?
|
| Esophageal Neoplasms | 1 | 2000 | 1654 | 0.010 |
Why?
|
| Energy Metabolism | 2 | 1996 | 2882 | 0.010 |
Why?
|
| Legislation as Topic | 1 | 1990 | 77 | 0.010 |
Why?
|
| Disease Reservoirs | 1 | 1970 | 121 | 0.010 |
Why?
|
| Genes | 1 | 1993 | 1823 | 0.010 |
Why?
|
| Pharmaceutical Preparations | 1 | 1977 | 1089 | 0.010 |
Why?
|
| Catheterization, Peripheral | 1 | 1993 | 343 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 1992 | 852 | 0.010 |
Why?
|
| Prosthesis Failure | 1 | 1994 | 1204 | 0.010 |
Why?
|
| Problem Solving | 1 | 1991 | 443 | 0.000 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 1970 | 177 | 0.000 |
Why?
|
| Zoonoses | 1 | 1970 | 179 | 0.000 |
Why?
|
| Acupuncture Therapy | 1 | 1993 | 486 | 0.000 |
Why?
|
| Radiotherapy Dosage | 1 | 1995 | 2898 | 0.000 |
Why?
|
| Neutralization Tests | 1 | 1970 | 728 | 0.000 |
Why?
|
| Mice | 2 | 1992 | 81539 | 0.000 |
Why?
|
| Catheterization | 1 | 1993 | 1428 | 0.000 |
Why?
|
| Urodynamics | 1 | 1989 | 346 | 0.000 |
Why?
|
| Cattle | 1 | 1992 | 3849 | 0.000 |
Why?
|
| Body Image | 1 | 1991 | 638 | 0.000 |
Why?
|
| Portography | 1 | 1986 | 11 | 0.000 |
Why?
|
| Patient Education as Topic | 1 | 1996 | 2319 | 0.000 |
Why?
|
| Critical Care | 1 | 1998 | 2697 | 0.000 |
Why?
|
| Stem Cells | 1 | 1998 | 3524 | 0.000 |
Why?
|
| Putamen | 1 | 1986 | 292 | 0.000 |
Why?
|
| Globus Pallidus | 1 | 1986 | 250 | 0.000 |
Why?
|
| Length of Stay | 1 | 1998 | 6426 | 0.000 |
Why?
|
| Occipital Lobe | 1 | 1986 | 374 | 0.000 |
Why?
|
| Ischemia | 1 | 1993 | 1884 | 0.000 |
Why?
|
| Kidney Neoplasms | 1 | 2000 | 4251 | 0.000 |
Why?
|
| Alpha Rhythm | 1 | 1984 | 111 | 0.000 |
Why?
|
| Delta Rhythm | 1 | 1984 | 81 | 0.000 |
Why?
|
| Gene Frequency | 1 | 1990 | 3606 | 0.000 |
Why?
|
| Urinary Bladder | 1 | 1989 | 1152 | 0.000 |
Why?
|
| Communication | 1 | 1996 | 3873 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1998 | 18966 | 0.000 |
Why?
|
| Preventive Health Services | 1 | 1986 | 567 | 0.000 |
Why?
|
| Education, Medical, Continuing | 1 | 1986 | 823 | 0.000 |
Why?
|
| Clinical Laboratory Techniques | 1 | 1986 | 746 | 0.000 |
Why?
|
| Aspirin | 1 | 1992 | 3133 | 0.000 |
Why?
|
| Mesencephalon | 1 | 1982 | 332 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1995 | 4026 | 0.000 |
Why?
|
| Thalamus | 1 | 1986 | 1047 | 0.000 |
Why?
|
| Rural Population | 1 | 1970 | 2285 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1998 | 18255 | 0.000 |
Why?
|
| Prostatic Neoplasms | 1 | 2000 | 11122 | 0.000 |
Why?
|
| Socialization | 1 | 1977 | 87 | 0.000 |
Why?
|
| Juvenile Delinquency | 1 | 1977 | 117 | 0.000 |
Why?
|
| Cerebrovascular Circulation | 1 | 1982 | 2727 | 0.000 |
Why?
|